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ABSTRACT
Bone injuries are commonly termed as fractures and they vary in their severity 
and causes. If the fracture is severe and there is loss of bone, implant surgery is 
prescribed. The response to the implant depends on the patient’s physiology and implant 
material. Sometimes, the compromised physiology and undesired implant reactions lead 
to post-surgical complications. [4 ,5,20,28] Efforts have been directed towards the 
development of efficient implant materials to tackle the problem of post-surgical implant 
failure. [15,19,24,28,32]
The field of tissue engineering and regenerative medicine involves the use of cells 
to form a new tissue on bio-absorbable or inert scaffolds. [2, 32] One of the applications 
of this field is to regenerate the damaged or lost bone by using stem cells or 
osteoprogenitor cells on scaffolds that can integrate in the host tissue without causing any 
harmful side effects. [2,32] A variety of natural, synthetic materials and their 
combinations have been used to regenerate the damaged bone tissue. [2, 19,30,32,43] 
Growth factors have been supplied to progenitor cells to trigger a sequence of 
metabolic pathways leading to cellular proliferation, differentiation and to enhance their 
functionality. [56, 57] The challenge persists to supply these proteins, in the range of 
nano or even picograms, and in a sustained fashion over a period of time. A delivery 
system has yet to be developed that would mimic the body’s inherent mechanism of
delivering the growth factor molecules in the required amount to the target organ or 
tissue.
Titanium is the most preferred metal for orthopedic and orthodontic implants. [28, 
46,48] Even though it has better osteogenic properties as compared to other metals and 
alloys, it still has drawbacks like poor integration into the surrounding host tissue leading 
to bone resorption and implant failure. [20,28, 35] It also faces the problem of post- 
surgical infections that contributes to the implant failure. [26, 37]
The focus of this dissertation was to design and develop novel implant materials 
for coating titanium to improve its biological properties. These natural and/or semi­
synthetic materials improved cellular adhesion, biological response to the scaffolds and 
prevented growth of bacteria when they were enhanced with growth factor and anti- 
infective loaded nanotubes. The implant materials showed promise when tested in vitro 
for cell proliferation, differentiation and bacterial growth inhibition.
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CHAPTER 1
INTRODUCTION AND BACKGROUND
The National Ambulatory Medical Care Survey and the American Academy of 
Orthopedic Surgeons estimate that in the United States annually over 6.8 million cases of 
bone injuries are brought to medical attention. [4, 5] The cause of these bone injuries 
varies from trauma in young individuals to osteoporosis or a combination of both in old 
aged patients. [17] Depending upon the severity o f the injury and the patient’s 
physiological condition, the treatment can vary from immobilizing the bone in a cast or 
surgical implants. [17] Response to the treatments, especially in case o f implants, varies 
depending upon the patient physiology and the type of implant material. Most of the 
implant materials available commercially have some drawbacks and can cause painful 
complications in the patients post-surgery.
The field of orthopedic and orthodontic tissue engineering and regenerative 
medicine directs its efforts to develop novel materials that can be used to improve the 
implant materials. In order to design better implants and develop improved scaffolds, we 
need to understand bone injuries, bone regeneration, the current treatments and their 
drawbacks. The following sections in this chapter explain in detail the skeletal system, 
anatomy and physiology of bone and summarize the current treatments and their 
limitations.
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21.1 Skeletal Tissue System and Bone
Skeletal tissues are involved with the prime purpose of providing support to the 
body, protection to the vital organs, and locomotion. This is achieved by well- 
coordinated and concerted actions of various tissues within the skeletal and nervous 
system. The major components of the skeletal tissue system are bones, muscles, cartilage, 
ligaments and tendons. The following subsections explain bone anatomy, the types of 
bone, and its cellular components.
1.1.1 Bone
Bone is a connective tissue consisting of organic and inorganic components. The 
organic components of bone include an extracellular matrix and three types of cells; 
osteoblasts, osteocytes and osteoclasts. The inorganic part of the bone consists of 
minerals including calcium, phosphorous and magnesium which act as the body’s 
reservoir of these salts. Bone has a vascular supply in the form of a network of arteries, 
veins and capillaries as well as lymphatic vessels. Bone also contains marrow in its 
stroma or inner hollow space which is a reservoir of stem cells that houses hemopoeitic 
cells as well as skeletal tissue cells. [21,34,44] Bone is a rigid organ but is also dynamic 
in nature and is able to regenerate as old bone disintegrates and a new one is formed. The 
mechanism of constantly replacing old bone with a new one is achieved by bone 
progenitor cells, and osteoblasts which lay new foundations and the old bone is resorbed 
by bone resorptive cells, called osteoclasts. Osteoclasts release metalloproteases which 
digest the old bone minerals in the matrix, giving way to new bone formation. [23,47] 
Figure 1-1 shows bone anatomy in detail.
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Figure 1-1. Graphical Representation of the Bone Anatomy. [18]
1.1.2 Types o f Bones
Based on the length, bones can be classified into five types: long, short, flat, 
sesamoid and irregular. The characteristics and examples of the five types are as follows:
1. Long Bone: Long bones have a shaft which is longer in length than width. The 
articular surfaces of the long bones (epiphyses) are rounded and covered 
mostly with articular cartilage. The middle long and slender region 
(diaphyses) is made up of compact bone. However, the rounded articulating 
part is made of spongy, cancellous bone, e.g. femur, humerus and tibia. [21, 
23, 34 ,44,47]
2. Short Bone: Short bones can be said to have a cubic shape and have mostly 
spongy bone surrounded by a thin layer of compact bone. Examples of short 
bones are the small bones of ankles and wrists. [21,23, 34 ,44,47]
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43. Flat Bone: Flat bones are curved and thin. They consist of two layers of thin 
compact bone and a thin layer of spongy bone in between. They are found in 
die skull and sternum. [21, 23, 34 ,44 ,47]
4. Sesamoid Bone: Bones embedded in tendons are called sesamoid bones and 
are found in the articular joints like the knee joint. They resemble short bones 
in their shape and carry out the function of holding the tendon away from the 
bone and increasing the muscle leverage. An example of the sesamoid bone is 
the patella in the knee joint. [21,23, 34,44 ,47]
5. Irregular Bone: Any bone not fitting into the above categories is classified as 
irregular bone. As the name suggests, these bones have irregular shapes. They 
are spongy bones surrounded by a thin mass o f compact bone and are found in 
die vertebral column, pelvic girdle and in the skull. [21,23, 34 ,44,47]
1.1.3 Cellular Components of Bones
Bone consists of three types of cells: osteoblasts, osteocytes, and osteoclasts.
These cells originate in the bone marrow present in the medullary cavity. [16,23,47]
1. Osteoblasts: Osteoblasts, like other skeletal tissue cells, are derived from the 
mesenchymal stem cells present in the bone marrow. They are also called 
bone progenitor cells as they form the new bone matrix. A variety o f growth 
factors play in concert with each other to differentiate the osteoblasts and 
secretion of bone matrix. [16,23,47]
2. Osteocytes: Osteoblasts on maturation are called osteocytes. These cells are 
metabolically less active than osteoblasts but help maintain the bone matrix. 
They are found in small cavities in the bone mineral matrix secreted by them,
5called lacunae and form a network of cytoplasmic processes called canaliculi. 
[16,23,47]
3. Osteoclasts: Osteoclasts are large motile macrophages present in the bone 
matrix and are involved in resorption of old bone matrix. Osteoclasts originate 
from the hematopoietic stem cells like other macrophages, have a monocytic 
lineage and inherit the property of phagocytosis. They play an important role 
in calcium homeostasis. [16,23,47]
1.2 Bone Injuries and Tissue Repair
Bone injuries are generally called fractures and have various causes. [23,47, 51] 
Bone can fracture due to high impact or stress as in the case o f trauma or a low impact or 
stress as in cases o f osteoporosis, bone cancer, and osteogenesis imperfecta. [9,23,47,
51] When bone fracture is caused due to pathological causes such as cancer, osteoporosis, 
or osteogenesis imperfecta; it is termed a pathological fracture.
The tissue repair and regeneration process in bone depends on the patient’s 
physiological condition and age. [9, 51] Disorders like diabetes mellitus, osteoarthritis, 
and other pathologies complicate and delay the process of tissue repair. [9, 51] Bone 
healing is also slow in older patients as compared to younger patients. [9, 51]
Tissue repair in bone involves a sequence of events that uses stem cells, 
osteoprogenitor cells and various molecular triggers responsible for stimulating migration 
of these cells and their differentiation. The events of bone tissue repair can be 
summarized as follows and are depicted pictorially in Figure 1-2:
61. Reactive phase (Hematoma formation): Initial inflammatory response and 
secretion of cytokines and growth factors. The secretion of cytokines and growth 
factors signal the progenitor cells to migrate to the site of injury.
2. Reparative phase (Soft and Hard Callus formation): Proliferation of the progenitor 
cells that will replace the damaged tissue.
3. Remodeling phase: Differentiation of proliferated progenitor cells forming a new 
tissue that will be functional just like the old tissue. [9,16,47, 51]
Figure 1-2. Graphical Representation of Phases of Bone Healing. [3]
1.3 Current Treatment Modalities
A variety of treatment modalities are used to assist the natural repair and 
regeneration response of the body. In cases where the response is hindered due to 
patients’ physiological state or complexity of the injury, natural or artificial implants are 
used. The treatment also involves use of pain killers, physiotherapeutics and other 
assistive drugs. [14]
7In severe cases of fractures where the gap between the broken bones is large and 
the bone structure becomes unstable, surgery is prescribed to stabilize the bones. Metal 
implants (titanium plates and/or screws) are used to hold the bones in place. [14, 51] In 
extreme trauma, compromised physiological condition and/ or old age, the surgery can be 
a complicated procedure and healing can be problematic. [51] For convenience, the 
implant materials discussed in this dissertation are broadly categorized as having a 
biological and non-biological origin. The implant materials and their limitations are 
described in the sections below.
1.3.1 Biological Implants
The implants that are derived from biological materials or are composed of 
biological materials are categorized as biological implants. These types of implants 
include biological tissues, decellularized tissue matrix, and materials isolated and purified 
from the tissues of organisms. [36,46] Focusing on the orthopedic and orthodontic 
implants, the biological orthopedic and orthodontic implants are bone grafts. Depending 
on the origin of bone grafts, they are further categorized into autografts and allografts.
1.3.1.1 Autoerafts. Autografts are derived from the same individual who needs the 
implant. [46] The bone is usually taken from the iliac crest, spine, or ribs. The process 
of surgically removing the graft from a healthy donor site is called harvesting. This type 
of implant procedure is performed in the spine fusion surgery. [46] Autograft poses 
risks such as donor site morbidity, infection, chronic pain at the site o f harvesting, and 
nerve injury during the harvesting procedure. [33,46] Bone autografts are employed 
less in recent times due to development of better alternative methods. [15,56]
81.3.1.2 Allografts. Allografts are harvested from cadavers by a tissue bank.
Allografts have drawbacks such as lower chances of bone fusion, risk of disease 
transmission, and undesirable immune response to the graft by the host tissue. [15,56]
1.3.2 Non-Bioloeical Implants
The implants that are composed of materials having synthetic, inorganic or non- 
biological origin are categorized as non-biological implants. The non-biological 
orthopedic and orthodontic implants are metal implants and polymer implants. Their 
nature and limitations are described in detail below.
1.3.2.1 Metal implants. The most commonly used metals or metal alloys for implants 
are stainless steel, vitallium (cobalt -  chromium alloy), and titanium. [28] Due to 
corrosion after implantation, stainless steel has been replaced by vitallium and titanium. 
[28] In the recent years, titanium has become a popular choice as metal implant 
material. Titanium implants are made of either pure titanium or as an alloy of titanium 
with vanadium and aluminum.
While titanium as an implant material has virtues such as good osteointegration 
compared to other metals, is less corrosive because of the oxide layer forming on the 
surface of the metal, and produces less scatter during Computational Tomography Scan 
(CT Scan) and Magnetic Resonance Imaging (MRI), recently it has been linked with 
undesirable immune response in some patients. [53] Titanium implants also have high 
failure rates due to post-surgical infections. [49]
1.3.2.2 Polymer implants. Polymer implants are used widely for both bone and soft 
tissue reconstruction. [19] Polymers are long chains of repeating monomers forming 
macromolecules attaining high molecular weights. The most commonly used
9biomaterial polymers are polymethylmethacrylate, silicone, polyethylene, 
polypropylene, nylon, and poly-e-caprolactone. [19]
Silastic implants (elastic silicone implants) have severe side effects like capsule 
formation and contracture. [19,43] Silicone implants in arthroplasty cause silicone 
synovitis. [43] Complications related to polymethylmethacrylate are cause by the high 
setting temperatures and an exothermic reaction, which leads to bone necrosis. 
Polymethylmethacrylate can also cause tissue toxicity due to the presence of unbound 
monomer, methyl methacrylate. [27] Other polymer materials lack the tensile and 
compressive strength of the natural tissue and do not integrate well with the tissue. [30]
1.4 Clinical Need for Improved Implant Materials
Drawbacks in commercially available metal implant materials range from mild 
immune reactions, such as allergies, to more severe consequences, such as bone 
resorption. [49, 53] Commercially available polymers need significant improvements 
with respect to their tissue integration potential and mechanical properties. [27,30,43] 
Implant materials are needed that are tissue integrative, biodegradable, 
immunocompatible, and similar in mechanical properties to the natural tissue. These 
implants should help the regeneration of the damaged tissue and should either exist in the 
body inertly after the healing process is complete or should be resorbed in the body as 
non-toxic or excreted out.
CHAPTER 2 
TISSUE ENGINEERING AND ENHANCED MATERIALS IN 
REGENERATIVE MEDICINE
Tissue engineering is an emerging field that combines the use of cells, 
engineering, and materials along with suitable biochemical and physicochemical cues to 
improve or replace the biological functions. [32] Natural tissues require a specific 
biological and mechanical structure to perform their regular functions. Due to either 
injury or organic failure the natural tissue might lose its structural integrity and fail to 
perform its natural function. [32] Tissue engineering attempts to regenerate the damaged 
tissue and restore its functionality.
The term regenerative medicine even though used in relation to tissue engineering 
is focused on the use o f the stem cells or progenitor cells to repair or replace the damaged 
tissue. [2,32] The damaged tissue is repaired using a scaffold based approach. [2, 32] A 
suitable biomaterial is selected and seeded with either differentiated cells, stem cells or 
progenitor cells. These cells are guided by mechanical and /or biochemical signals. Once 
die cells adhere to and populate the scaffold under the influence of mechanical andor 
biochemical signals, they differentiate and produce the extracellular matrix. Depending 
on the type of the cells and tissue, the cells will produce the marker molecules and 
regenerate the damaged tissue. [2,32,54]
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Bone injuries, as discussed in the earlier chapter, are commonly referred to as 
fractures. Depending upon the severity of the injury and patient physiology, the treatment 
may involve simple and common procedures like immobilization of the bone by 
application of casts or surgical procedures to fix the bone internally using metal plates 
and screws. [4, 5, 17] Commercially available materials used for the fixative and 
reparative bone surgeries have drawbacks that are discussed in detail in the previous 
chapter. [24] Recent advances in the field of tissue engineering and regenerative 
medicine have made it possible to design bioactive polymers that bridge the gap between 
natural tissue and artificial implant materials. [2, 32, 54] These polymers can be either o f 
natural, synthetic or composite in origin. By applying engineering principles and 
modifying the material properties of these implant materials we can incorporate bioactive 
molecules in their mesh networks. [54] This approach can be used for in situ delivery of 
the bioactive molecules reducing the risks to other systemic organs.
Depending on their design and the placement of the cells, the enhanced and 
engineered biomaterials can then be used either as an assistive tool for the body’s natural 
regenerative process to accelerate the healing of injury, or to compensate for the loss of 
regenerative potential due to compromised physiology. These biomaterials can also be 
used to improve the performance o f the implants. The biomaterials should have good 
osteointegration and osteoconduction for the implant to succeed. These materials also 
should possess mechanical strength comparable to the native tissue.
Most of the polymers that are used for bone tissue regeneration lack material 
strength and the metal implants lack the porosity and osteointegrative properties. If the 
polymer composites are used in combination with metal implants, both the materials can
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compensate for the missing properties. Addition of nanoparticles for sustained delivery of 
bioactive molecules and surface modification can make the bioengineered scaffolds 
desirable to the cells. With modified surface properties and secretion of bioactive 
molecules the new nanoenhanced composites hold promise to fulfill at least some of the 
important criteria of good implant materials.
2.1 Rationale Behind the Three Integrated Projects
This chapter describes the three integrated and interrelated projects that focus on 
the repair of the damaged bone tissue by applying principles of tissue engineering and 
regenerative medicine. The interrelated projects make use of the enhanced bioactive 
scaffolds as a base or a template for the progenitor cells to lay a foundation of new tissue 
to replace the damaged bone tissue. In these projects, hydrogels were made from natural 
organic and inorganic substances through polymer crosslinking. These hydrogels 
enhanced with nanoparticles were used as in situ delivery vehicles for the bioactive 
molecules.
The nanoparticles, namely halloysites, would contain the bioactive molecule of 
choice. Since the bioactive molecules would be contained inside the nanoparticles and 
hydrogels would hold the nanoparticles in their mesh network, the release would be 
sustained and extended when compared to the release from the hydrogels alone. With this 
scheme of design, the hydrogels can be modified for their function by changing the 
bioactive molecule loaded inside the halloysites.
If the progenitor cells are the target, growth factors like BMP 2,4, and 6 can be 
used to improve the cellular response of the cells encapsulated in the hydrogel mesh
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network. This design can be used to deliver cells with a package of boosters for 
differentiation at the site of injury.
The construct with the progenitor cells encapsulated in the hydrogels would aid 
the damaged tissue which might have lost its potential for repair if the body has 
compromised physiology. If the objective is to attract the stem and progenitor cells to the 
site of injury, the hydrogels enhanced with growth factor loaded halloysites can be used. 
The secreted growth factors would act as a biochemical signal to attract the cells to the 
site of injury. The nanoenhanced hydrogels can be used to coat the surface of metal 
implants especially titanium, to improve cellular response, integration into host tissue, 
and to prevent microbial growth on the implant surface. The titanium metal surface can 
be modified by anodization to increase its surface roughness and to improve the 
osteogenic response. Figure 2-1 illustrates the rationale behind the three interrelated 
projects. Sections 2.2,2.3, and 2.4 describe the projects in detail.
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Figure 2-1. Graphical representation of the rationale behind the three interrelated 
projects. [10,11]
2.2 Nanoenhanced Bioactive Hydrogels
The term hydrogel was used in 1894 for the first time in literature. [42] Hydrogels 
are made of network of polymer chains that are hydrophilic in nature, hydrogels have 
water as their dispersion medium and 90% of their weight is water. [41] This property of 
hydrogels makes them very flexible and similar to natural tissue. [41] Hydrogels are 
commonly used as scaffold materials in tissue engineering. The mesh network of the 
hydrogels mimics the 3D environment of the natural tissue making them ideal for cellular 
growth and response. [41, 55]
Hydrogels can be made from natural or synthetic materials depending on the 
application. In tissue engineering, both the natural as well as synthetic materials are used
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for making hydrogels, e.g. natural materials like alginic acid, chitosan, hyaluronic acid, 
collagen, agarose and synthetic materials like polyvinyl alcohol, polyacrylamides, 
silicone, etc. [41, 55]
In the first of the three interrelated projects, hydrogels were made from natural 
and synthetic materials through polymer crosslinking. The materials used were alginate, 
chitosan and calcium phosphate. Alginate and chitosan are FDA approved and biphasic 
calcium phosphate is commonly used as an alternative in bone grafts. The hydrogels 
contained embedded halloysites doped with bone morphogenic proteins.
Previous work on alginate-HNT scaffolds doped with BMP 2 showed promising 
results using the cell line ATCC 7F2 CRL 12557 mouse osteoblasts. The work was 
continued with BMP 4 and 6 loaded HNTs on the cell line ATCC 7F2 CRL 12557 mouse 
osteoblasts. The cell lines, ATCC CRL 2593 MC3T3 El subclone 4, a mouse pre­
osteoblast cell line and ATCC CRL 2623, a mouse mesenchymal stromal cell line were 
also tested on the hydrogels with BMP 2 loaded halloysites. The composite hydrogels 
composed of alginate-chitosan and alginate-calcium phosphate were tested for their 
biological and mechanical properties. These nanoenhanced bioactive hydrogels can find 
application in implant coatings as well as stand-alone filler materials for bone 
regeneration. Figure 2-2 shows the graphical representation of the concept of the 
nanoenhanced bioactive hydrogels.
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2.3 Nanoseeds
The objective of this study was to investigate the potential of BMP 2 loaded into 
halloysites as a chemoattractant agent to actively recruit cells into the damaged tissue and 
thus advance tissue healing and repair. The principal goal of this research was to develop 
a novel nanocomposite, a Nanoseed composed of halloysite clay nanotubes (HNTs) 
nanoparticle composites, doped with osteogenic chemoattractants and inserted within 
biocompatible hydrogels (alginate, calcium phosphate or chitosan). The hydrogel 
construct was termed a Nanoseed because of the nanotubes that were incorporated into 
the hydrogels’ mesh network. Nanoseeds, containing the chemoattractant BMP 2 loaded 
HNTs, were placed on the collagen gel matrix with bone progenitor cell reservoirs. These 
constructs were then assessed for their ability to actively recmit osteoprogenitor cells to
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produce a bone matrix. The experimental design and the concept of Nanoseed are 
illustrated in Figure 2-3.
Figure 2-3. The experimental design and the concept of Nanoseed.
2.4 Hydrogel Biocoatings for Titanium Implants
Post-surgical infections are a major reason for the metal implant failures. [20] 
Titanium, a favored choice for metal implants, faces the problem of bacterial biofilm 
formation leading to its failure. [37] There are studies on coating the surfaces of the metal 
implants with anti-microbial coatings, but these coatings could not prevent the formation 
of bacterial film. [26] The major reason for the failure of anti-microbial coatings is the 
failure to release the anti-microbial drugs in a controlled and sustained manner. [26, 39,
52] The coatings either broke down early in the body’s internal environment or failed to 
release the drug. [39, 52]
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In the hydrogel biocoating project, there are two major goals: the first is to 
prevent the formation of bacterial films and the second is to make the surface of the 
titanium favorable to the bone cells for attachment and proliferation. Calcium phosphate 
bone cement has been used in combination with alginate and chitosan and enhanced these 
hydrogels with anti-microbial agent loaded halloysites. Gentamicin Sulfate (GS) was 
used as the anti-microbial agent because of its heat stability, wide use in the orthopedic 
surgeries and its effectiveness against the gram negative strains of bacteria. [8,38] To 
achieve better surface for cellular response, the titanium surface was modified by 
anodization.
The hydrogel biocoatings were tested for their effectiveness in achieving a 
controlled and sustained release of the drug as well as their ability to inhibit the 
bacterium. Anodization was done by acid etching using Hydrofluoric acid (HF) as the 
electrolyte. The surface morphology of the anodized titanium was studied by scanning 
electron microscopy. The anodized titanium was also tested to check if it retained its 
osteogenicity by examining the deposition of hydroxyapatite crystals by treating it with 
simulated body fluid. The graphical representation of the concept of hydrogel coatings 
for anodized titanium is shown in the Figure 2-4.
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Figure 2-4. Graphical representation of the concept of hydrogel coatings for anodized 
titanium.
2.5 Objectives of the Projects
The basic objective of all the three projects is to design scaffolds that are 
cytocompatible, tissue integrative, tissue conductive, and would resemble native tissue in 
their material properties. The detailed objectives of the individual projects are listed 
below:
1. To design bioactive enhanced hydrogels with growth factor molecules loaded in 
them to improve the cellular response and surface morphology.
2. To obtain a sustained and extended release of growth factors and anti-infectives 
from the nanoparticles and hydrogels enhanced with nanoparticles.
3. To check the surface and other material properties of the hydrogels enhanced with 
nanoparticles.
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4. To investigate if the nanoenhanced hydrogels act as a chemoattractant to the 
progenitor cells.
5. To anodize titanium and investigate its surface properties with respect to 
osteogenicity.
6. To design anti-infective hydrogels that would inhibit microbial growth and can be 
used to coat anodize titanium.
CHAPTER 3
INSTRUMENTATION AND METHODS
The current chapter details the instrumentation and methods used for scaffold 
preparation, material characterization of the scaffolds, and the response of different cell 
types to the scaffolds.
3.1 Instruments
Instruments form an important means of investigating a variety of scaffold
properties. The following subsections detail the instruments used in the current
dissertation. The instruments and the types of data they produced are detailed below.
3.1.1 HITACHI S 4800 Field Emission-Scanning Electron 
Microscope and EDX
HITACHI S 4800 Scanning Electron Microscope (FE-SEM) was used to image 
the hydrogel and titanium metal surfaces. The high magnification attained by the FE- 
SEM allowed a close comparison of the surface morphologies of the hydrogels and 
titanium (anodized and non-anodized). This comparison helped in the assessment of the 
surface properties and in predicting the behavior o f the scaffolds in simulated body 
conditions. Figure 3-1 shows HITACHI S 4800 FE-SEM at the Institute of 
Micromanufacturing, Louisiana Tech University, Ruston (IfM).
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Figure 3-1. HITACHI S 4800 FE-SEM at Institute of Micromanufacturing, Louisiana 
Tech University. [12]
3.1.2 NOVA e2000 B. E. T. Surface Area and Pore Size Analyzer
Brunnauer-Emmett-Teller or B. E. T Surface Area and Pore Size analysis works 
on the principle of physical adsorption of gas molecules on the surface o f solid materials. 
[31 ] This theory by Brunnauer-Emmett-Teller is based on the Langmuir theory which 
assumes that the adsorbate, in this case an inert gas, behaves as an ideal gas under 
isothermal conditions and its partial pressure is directly proportional to its volume 
adsorbed on the solid surface. [31,40]
NOVA e2000 Surface Area and Pore Size Analyzer works on the B. E. T. 
principle and can measure surface area and pore size of the sample using the helium void 
volume method. For our hydrogel samples, we have used the Langmuir method of 
plotting the isotherm. But the instrument, NOVA e2000, can perform other types of
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computational analyses such as V-t method, DR method, etc. Figure 3-2 shows NOVA 
e2000 Surface Area and Pore Size Analyzer at IfM.
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Figure 3-2. NOVA e2000 Surface Area and Pore Size Analyzer at Institute of 
Micrmanufacturing, Louisiana Tech University. [1]
3.1.3 NANODROP 2000 Spectrophotometer
NANODROP 2000 from Thermo Scientific is a UV-VIS spectrophotometer 
which uses only 1 pi of the sample for DNA, RNA, Protein, and other assays for 
biochemical analyses. This instrument also analyzes the samples within few minutes. 
Either a cuvette (for dilute samples) or the pedestal can be used for the analyses of the 
samples and the results can be obtained in the form of graphs on the software that is 
linked to the instrument. [6]
NANODROP 2000 spectrophotometer was used to measure the samples from the 
release study samples as well as the histochemical analyses. NANODROP 2000 used for
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this research was located in the common second floor lab in the Biomedical Engineering 
building, Louisiana Tech University. Figure 3-3 shows Thermo Scientific NANODROP 
2000 spectrophotometer.
Figure 3-3. Thermo Scientific NANODROP 2000 spectrophotometer
3.1.4 Olympus BX51 Fluorescent Microscope
The Olympus BX51 fluorescent microscope images cells live or in the fixed state. 
It has filters for different fluorescent dyes such as DAPI, Alexa Fluor Red, FITC, and 
TRITC. This microscope can also image the cells in phase contrast mode when the UV 
lamp is turned off. The images are captured in high definition and can be taken at 10X, 
20X or 40X magnifications.
For visualizing the cells stained with different histochemical stains and 
fluorescent dyes we used 10X and 20X magnifications. The scaffolds and the seeded cells 
were also imaged on the phase contrast mode. Figure 3-4 shows Olympus BX51
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epifluorescence microscope in the microscopy lab in the Biomedical Engineering 
Building.
Figure 3-4. Olympus BX51 epifluorescence microscope in BME microscopy lab, 
Louisiana Tech University.
3.1.5 LABCONCO Lvoohilizer
Lyophilizer freeze dries the samples under low temperature and vacuum. This 
method of drying preserves most of the structural details of the samples, especially, 
hydrogels. For electron microscopy, the samples need to be dry and if hydrogels are dried 
under vacuum at room temperature their structure collapses turning the hydrogel beads 
into powder. Lyophilizer uses temperatures as low as — 20 °C retaining the structural 
features while at the same time drying the samples.
The hydrogel samples were frozen at - 2 0  °C overnight and then subjected to 
vacuum conditions in the LABCONCO lyophilizer. The process was carried out for 36 
hours. The samples obtained were stored at room temperature under dry conditions. 
Figure 3-5 shows the LABCONCO lyophilizer located in Biomedical Engineering 
building Room 151.
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Figure 3-5. LABCONCO lyophilizer in BME 151, Louisiana Tech University.
3.1.6 Absorbance Microplate Reader
The principle of absorbance microplate reader is similar to that of 
spectrophotometer the only difference being the stage on which the samples are mounted 
for analyses. Absorbance microplate reader utilizes a stage that can read 96 well plates or 
similar plates that are used for cell culture and ELISA studies.
For the quantification of released bioactive molecules in the release profile studies 
using ELISA, Phenix LT-4000 absorbance microplate reader was used. The assays were 
done in a 96 well plate specially treated for ELISA. Figure 3-6 shows Phenix LT-4000 
absorbance microplate reader in Biomedical Engineering building Room 238.
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Figure 3-6: Phenix LT-4000 absoibance microplate reader in BME 238, Louisiana Tech 
University.
3.1.7 Anodization Set-Up
Anodization uses the metal to be coated and etched as an anode. The method used 
in this research for etching on the surface of titanium is acid etching. Hydrofluoric Acid 
(HA) was used as an etchant and titanium metal sheet (polished manually with alumina) 
was used as an anode. Oure platinum electrode was used as cathode. A voltage of 1 V 
was applied with a current of 10 amps. Figure 3-7 shows the anodization set up in 
Carson-Taylor Hall Room 316.
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Figure 3-7. Anodization set-up at Carson-Taylor Hall room 316, Louisiana Tech 
University.
3.2 Methods
Detailed in the following sub-sections are the methods used to construct the 
scaffolds, prepare samples for various analyses and biochemical assays used for 
determination of the cellular response to the scaffolds.
3.2.1 Preparation of Hydrogels
Hydrogels are formed by crosslinking monomers into long interlinked polymers. 
They have a mesh like network that can be attributed to the chemistry of their bonds. 
Hydrogels can hold large amounts of water molecules in their structure giving them their 
name.
In current research, calcium alginate hydrogel forms the base of all the hydrogel 
composites. Sodium alginate 2% w/v was reverse crosslinked with 1% w/v calcium
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chloride. The hydrogel composites consisted of the following materials in specific 
concentrations are shown in Table 1.
Table 1: Materials in specific concentrations used for hydrogel composites
Alginate
Only
2% w/v 
sodium 
alginate
1% w/v 
calcium 
chloride
Alginate + 
HNTs
2% w/v 
sodium 
alginate
1% w/v 
calcium 
chloride
1% w/v 
HNTs
Alginate + 
TTCP
2% w/v 
sodium 
alginate
1% w/v 
calcium 
chloride
0.33 gm TTCP 
per 1 ml 
alginate 
solution
Alginate + 
TTCP + 
HNTs
2% w/v 
sodium 
alginate
1% w/v 
calcium 
chloride
1% w/v 
HNTs
0.33 gm TTCP 
per 1 ml 
alginate 
solution
Alginate + 
TTCP + 
Chitosan
2% w/v 
sodium 
alginate
1% w/v 
calcium 
chloride
0.167 gm 
TTCP per 1 ml 
alginate 
solution
3.33 mg 
Chitosan 
lactate per 1 
ml alginate 
solution
Alginate+ 
TTCP + 
Chitosan + 
HNTs
2% w/v 
sodium 
alginate
1% w/v 
calcium 
chloride
1% w/v 
HNTs
0.167 gm 
TTCP per 1 
ml alginate 
solution
3.33 mg 
Chitosan 
lactate per 1 
ml alginate 
solution
3.2.2 Vacuum Loading of Hallovsite
HNTs were loaded with bioactive molecules like growth factors and anti­
microbial agents. The basic process of vacuum loading remained the same, with the 
concentrations differing according to the molecule of interest. For sterilizing them, the
HNTs were spread onto a parchment paper piece and kept under the UV light for 45 
minutes. Throughout the loading process aseptic conditions were maintained.
3.2.2.1 Loadine HNTs with Growth Factors. Bone Morphogenetic Proteins 2 ,4 , and 
6 were obtained from ProSpec Militany, Tel Aviv, Israel. A stock solution o f the 
respective growth factors was prepared as per the manufacturer’s instructions. A 
dilution of the concentration 10 pg/ml was prepared from the stock solution for all the 
three growth factors. All the solutions were made from sterile diluents and under 
aseptic conditions.
After sterilization under the UV light, the HNTs were sonicated for 15 minutes 
with the prepared growth factor solutions. The final concentration of HNTs to the growth 
factor solution is 50 mg HNTs in 10 ml of 10 pg/ ml growth factor solution. This solution 
was then kept in vacuum chamber under sterile conditions for 24 hours with intermittent 
vacuum applied to it. After 24 hours, the HNTs were separated by centrifugation and then 
washed in distilled water to remove traces of growth factors sticking on the outer surface 
of the tubes. After washing, the loaded HNTs were dried in vacuum and stored at 4 °C.
3.2.2.2 Loadine HNTs with Anti-Microbial Aeent. The anti-microbial agent used in 
the current research, Gentamicin Sulfate (GS), was obtained from Sigma-Aldrich, St. 
Louis, MO. A solution of 60 mg/ ml was prepared in autoclaved water. To the 10 ml of 
60 mg/ml solution of GS 50 mg HNTs were added and sonicated for 15 minutes under 
sterile conditions. This solution was then kept in vacuum chamber under sterile 
conditions for 24 hours with intermittent vacuum applied to it. After 24 horns, the 
HNTs were separated by centrifugation and then washed in distilled water to remove
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traces of growth factors sticking on the outer surface o f  the tubes. After washing, the 
loaded HNTs were dried in vacuum and stored at 4 °C.
3.2.3 Sample Preparation for FE-SEM
Lyophilization is a process where the sample is subjected to rapid drying under 
frigid and vacuum conditions. This is done to retain the structural details but to remove 
water molecules from the sample. FE-SEM requires the samples to be dry to obtain high 
magnification and high resolution images.
To lyophilize, the hydrogels were subjected to -20 °C temperature overnight 
before starting the process. This prevents the hydrogel structure and pores from 
collapsing under extreme low pressure. After freezing the samples, they were attached to 
the docks provided for the glass beaker and the vacuum was started. The process usually 
completes in 24 hours but the samples were kept running in the lyophilizer for 36 hours 
to ensure that they have no moisture.
3.2.4 Coating 12 Well Plates with Collagen Type I Gels
The cell migration experiments in the project ‘Nanoseeds’ required a gel matrix to 
hold the hydrogel constructs in place away from the cell reservoir. Collagen type I gel 
was the best suited option as it is the basic component of any tissue’s extra cellular 
matrix. This gel would mimic the conditions found in the natural tissue. The cell culture 
12 well plates were coated with collagen type I to obtain the gel matrix.
Rat tail type I collagen was obtained from GIBCO, Life Technologies and the 
collagen gel was prepared as per the procedure and formulae provided by the 
manufacturer.
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3.2.5 Cell Assays
Biochemical assays quantify the cellular response to the scaffolds and in turn can 
give us an idea about how the scaffolds behave in vitro.
3.2.5.1 Trypan Blue Cell Count for Seedim  Density. To fix the concentration of 
seeding the cells on to the scaffolds, we needed to quantify the number of cells in one 
T25 cell culture flask at 80% confluence. To calculate the amount of cells present in the 
flask, Trypan Blue cell viability method was used.
Cell suspension (1 ml) was taken from a passage 2,80% confluent T25 flask and 
0.1 ml of 0.4 % v/v Trypan Blue solution was added to it. A hemocytometer was used to 
determine the number of live and dead cells. If the cells take up the dye, they are non- 
viable and vice versa. Under a 10 X magnification o f the light microscope, the total 
number of cells and number of blue cells are counted in a hemocytometer. The number of 
viable cells is calculated as follows:
% viable cells = [1.00 -  (No. of Blue Cells / Total number of cells)] X 100 
Cells/ ml cell suspension = No. of Viable cells X 104 X 1.1
3.2.5.2 NucBlue Fluorescent Stainine. NucBlue Live Ready Probes fluorescent stain, 
Life Technologies, Thermo Fisher (Grand Island, NY) works on the same principle as 
the DAPI stain. It is a cell permeant nuclear dye that emits blue fluorescence when 
bound to the DNA. The staining procedure was carried out as per the manufacturer’s 
instructions. Three drops of the dye were added per ml of the cell suspension and 
incubated for 20 minutes protected from the light. The cells were visualized under 
Olympus fluorescence microscope under the DAPI filter.
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Results are not shown in Section 5.3 as the dye faded after Day 3 and the Days 
1 and 3 figures were not sufficient to suggest the migration of cells form the cell 
reservoir towards hydrogel ‘Nanoseeds’. The histochemical staining with Alcian Blue 
and Von Kossa were more conclusive to show the migration and differentiation of the 
cells towards the hydrogel ‘Nanoseeds’.
3.2.5.3 Alcian Blue Stainin2. Alcian Blue stains the acidic mucopolysaccharides of 
the ECM blue and helps to visualize the otherwise fuzzy ECM. This assay helps to 
assess the ECM production on the scaffolds or in response to them.
The fixed cells or the constructs with the cells were washed with HBSS and 
then stained with 0.5%v/v Alcian Blue stain from Electron Microscopy Inc. for 20 
minutes. The cells and the constructs were visualized under 10 and 20 X magnification 
of Olympus Light microscope.
3.2.5.4 Picrosirius Red Stainine. Picrosirius Red stain helps to visualize the 
collagen secretion by the cells when they are forming ECM. Collagen, especially type I, 
is a major component of ECM of a majority of the tissues in the body. Picrosirius Red 
stains collagen red, revealing the extent of ECM production and differentiation of the 
cells.
The fixed cells or the constructs with the cells were washed with HBSS and 
then stained with Picrosirius Red, Polysciences Inc. (Warrington, PA) solution A for 
two minutes and then in solution B for 60 minutes. After 60 minutes, solution B was 
removed and solution C was added and kept for two minutes. After the staining was 
completed, the excess stain was washed with distilled water. The collagen secretion 
was visualized under Olympus light microscope at 10 and 20 X magnification.
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3.2.5.5 Von Kossa Stainine. Von Kossa stain utilizes the reaction between 3% v/v 
silver nitrate solution and the phosphate group of calcium phosphate or hydroxyapatite 
molecules to visualize the calcium phosphate synthesis by the cells after differentiation. 
Bone progenitor cells produce calcium phosphate as a result of differentiating into the 
mature osteocytes. Calcium phosphate is the major inorganic content of bone.
The fixed cells or the constructs with the cells were washed with HBSS and 
then 3% v/v silver nitrate solution from Polysciences Inc. (Warrington, PA) was added 
to the wells. The solution and the constructs were the placed under UV light for 15 
minutes. After 15 minutes, the solution was discarded and the constructs washed with 
distilled water twice and 5% v/v sodium thiosulfate solution was added to the 
constructs to remove traces of unreacted silver nitrate. The constructs were then washed 
with distilled water twice. The black or brown stained phosphate deposits were 
visualized under Olympus BX51 brightfield microscope at 10 or 20X magnification.
3.2.6 Release Profile Study
The release profiles of bioactive agents were studied in simulated physiological 
conditions. Release profiles of the bioactive molecules were obtained from both loaded 
HNTS and hydrogels enhanced with loaded HNTs. The loaded HNTs or the hydrogel 
beads enhanced with loaded HNTs were suspended in sterile Hank’s Balanced Salt 
Solution (HBSS) and put on a rocker platform for uniform agitation. Samples were taken 
and stored in sterile tubes at 4 °C for further analysis. All the release profile experiments 
were performed at room temperature.
For growth factor release profile (BMP 2), the samples were collected at 24 hours 
and 7 days. The concentration was determined by performing ELISA on the stored
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samples. The samples were brought to room temperature before performing the assay.
The ELISA kits were custom made Quantikine kits for BMP 2 and obtained from R&D 
systems (Minneapolis, MN). The readings were taken on the absorbance plate reader. The 
concentration of the released BMP 2 at a particular time point was estimated by plotting 
standard curves of the known BMP 2 standards and finding the corresponding values of 
the concentration for a particular optical density reading.
The release profile for GS was carried out using similar method of agitation and 
sample collection. The samples were collected at 24 and 36 hours and stored at 4 °C. The 
method for estimating the concentration was OPT A colorimetric analysis. The readings 
were taken on UV/VIS NANODROP spectrophotometer. The concentration of released 
GS was estimated by plotting standard curves of known concentration standards of GS 
and finding the corresponding values of the concentration for a particular optical density 
reading.
3.2.7 Bacterial Inhibition Study
Bacterial inhibition study was done to assess the efficiency of GS when loaded in 
HNTs and encapsulated in hydrogels. Muller-Hinton LB agar plates were prepared as per 
the standard procedure and aseptic conditions were maintained throughout the study. 
DH5a strain of E. coli was used to study the effect of anti-infective agent by studying the 
formation of growth inhibition zone on the agar plates. A negative control plate had a 
lawn of bacteria growing without any anti-infective agent. Positive control plate had GS 
standard disc placed on the bacterial culture. The experimental plates had different 
compositions of hydrogels with and without the anti-infective agent GS. The study was
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conducted for 24 hours and the plates checked for the formation growth inhibition zones 
around the hydrogel constructs indicating the effectiveness of the anti-infective agent.
CHAPTER 4
NANOENHANCED BIOACTIVE HYDROGELS
4.1 Introduction
In the field of regenerative medicine, research efforts are directed at the 
development of scaffolds that are biocompatible and that assist in the body’s native 
regenerative response. Hydrogels are a commonly used scaffold. Hydrogels have been 
used extensively to deliver a wide variety of bioactive agents. [41, 55] Alginate is a FDA 
approved material, commonly used in drug delivery, cell and enzyme encapsulation. [13, 
58] One of the challenges faced by the hydrogels is the release o f biomolecules in 
extremely low amounts and in a sustained manner. [58]
To achieve this objective, the HNTs were loaded with growth factors like BMP 2, 
4 and 6. HNTs are cylindrical in their structure with concentric layers o f aluminosilicate 
and have a lumen which is charged. [7] This unique structure of the HNTs makes them 
suitable for loading a variety of charged molecules. [22] Previous studies on the HNTs 
have shown that they can be used to deliver bioactive molecules like anti-infective 
agents, proteins, etc. in a sustained manner. [22,29]
The hypothesis of this project was that HNTs would provide a sustained release of 
the growth factors and would improve the material and biological properties of the 
calcium alginate hydrogels.
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4.2 Materials and Methods
All the plastic wares, such as, syringes, centrifuge tubes, microcentrifuge tubes,
12 well plates, pipettes, etc. were purchased from Mid Scientific, St. Louis, MO. Cell 
culture media, buffers, and serum were purchased from Life Technologies, Grand Island, 
NY. Sodium citrate, sodium chloride, calcium chloride, sodium alginate, and HNTs were 
obtained from Sigma-Aldrich, St. Louis, MO. BMPs (BMP 2,4, and 6) were purchased 
from Prospec (Rehovat, Israel). Preosteoblast cell line MC3T3 subclone El (ATCC CRL 
2593) was obtained from ATCC, Manassas, VA. BMP 2 Quantikine ELISA Kit was 
obtained from R&D Systems, MN.
4.2.1 Cell Culture. Cell Seeding and Preparation of the Constructs
Preosteoblast cell line was the model used to study in vitro cellular response to the 
nanoenhanced hydrogels. This cell line exhibits osteoblast differentiation once supplied 
with ascoibic acid and after differentiation their behavior is similar to that of the calvarial 
osteoblasts. [50] Standard aseptic cell culture protocols were followed to proliferate, 
passage and dissociate the cells in sterile cell culture grade plasticware.
For encapsulation, after detaching them from the flasks, the cells were suspended 
in Sterile HBSS. After centrifugation, the cell pellet was isolated and then resuspended in 
fresh HBSS. The seeding density was determined by hemocytometer and tryphan blue 
solution. The procedure is described briefly in Section 3.2.5.1. The seeding density used 
was 1 X 106cells/bead.
For preparation of the hydrogel beads, all the solutions, such as, 2% w/v sodium 
alginate, 1% w/v calcium chloride, and HNTs (before loading) were sterilized. The HNTs 
were sterilized under UV for 45 minutes and the solutions were prepared in autoclaved
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reverse osmosis (RO) water. To ensure that the solutions have no contaminants, they 
were sterile filtered through 0.45 gm syringe filters. The HNTs were loaded as mentioned 
in Section 3.2.2.1.
The cells that were suspended in sterile HBSS were carefully dispersed in the 2% 
w/v sodium alginate solution. Cell culture plastic 24 well plates were set up with 1% w/v 
calcium chloride solution. The set up comprised of five groups: control group # 1, control 
group # 2, experimental group # 1: BMP 2, experimental group # 2: BMP 4, and 
experimental group # 3: BMP 6. The sodium alginate+ cells solution was dropped 
carefully using sterile 27-G syringes in the respective wells.
4.2.2 Sample Fixation and Histochemical Analyses
The samples were made in triplicates and the experiment was performed twice to 
check for the reproducibility of results. The hydrogels were formed instantaneously but 
the beads were kept in the calcium chloride solution for about 15 minutes to ensure 
complete gelation. After 15 minutes, the beads were washed twice with sterile HBSS and 
complete a-MEM was added as the growth medium for the cells.
The samples were fixed on days 0, 1 ,3,7, 14, and 21 and biochemical and 
histochemical analyses were performed. The detailed procedures for Alcian Blue, 
Picrosirius Red, and Von Kossa Staining are provided in Sections 3.2.5.3, 3.2.5.4, and 
3.2.5.5, respectively.
4.2.3 Release Profile Study for BMP 2
Release profile study for BMP 2 was done to understand the elution of the protein 
from HNTs. As the amount of the protein that would be eluted fell in the ranges of 
nanograms and pictograms, custom made ELISA kits were used. The Quantikine ELISA
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kits from R&D systems can estimate the amount o f BMP 2 as low as 50 picograms. The 
details o f the sample collection and overall procedure are provided in the Section 3.2.6.
4.2.4 FE-SEM Imagine and Material Testing
To visualize if the addition of HNTs had any effect on the surface morphology of 
Ae hydrogels, FE-SEM imaging was performed on lyophilized hydrogel samples. The 
Lyophilization protocol is detailed in Section 3.2.3.
The material properties such as porosity, and surface area were analyzed using 
BET method. The sample preparation was simple for BET Surface area and pore size 
analyzer (NOVA e2000). The hydrogels were dried on Whatman No. 1 filter paper till the 
excess water was drained. After partial drying, the initial weights of sample (respective 
hydrogel types) were recorded. The degassing step was skipped as the hydrogels char at 
temperatures as high as 300 °C. Langmuir method of plotting isotherm was used to 
analyze the results. The principle behind BET NOVA e2000 surface area and pore size 
analyzer is described in detail in Section 3.1.2.
4.3 Results and Discussion
This section represents the results and their discussion from the experiments 
mentioned in Section 4.2.
4.3.1 Histochemical Analysis
The results of histochemical analysis of the hydrogels enhanced with BMP 2,4, 
and 6 were compared to the previously obtained histochemical analysis results of the 
hydrogels enhanced with BMP 2 loaded HNTs from the thesis, Bioactive Hydrogels for 
TMJ Repair. [29] The comparison was done to investigate the potential of HNTs loaded 
with growth factors as an m situ drug delivery vehicle and also to test the primary
hypothesis of this project, that is, the addition of growth factor loaded HNTs improves 
the biological and material properties of hydrogels.
4.3.1.1 Alcian Blue stainine. The Alcian Blue assay was performed to visualize the
amount of acidic ECM mucopolysaccharides. Alcian Blue stains the acidic 
mucopolysaccharides, found in the extracellular matrix produced by the differentiating 
cells, blue indicating the extent of ECM production. Figures 4-1 to 4-4 show Alcian 
Blue staining of the alginate hydrogels enhanced with BMP 2,4, and 6 loaded HNTs 
with osteoblasts encapsulated in them. Figure 4-1 (A-F) shows Day 0 Alcian Blue 
staining of the alginate hydrogels with BMP 2,4, and 6 loaded HNTs. The Alcian Blue 
staining was performed on fixed hydrogel beads on days 0 ,1 ,3 , 7,14, and 21. The 
figures are representative and only days 0 ,7 ,14  and 21 are shown in this dissertation as 
they show the progression of ECM production after cellular differentiation in the 
different experimental groups of hydrogels with growth factors and HNTs.
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Figure 4-1. Alcian Blue staining Day 0 A) Control 1 Alginate-only B) Control 2 Alginate 
+ HNTs C) Experimental 1 Alginate+ HNTs+ BMP 2 D) Experimental 2 Alginate+ 
HNTs+ BMP 2 with 0.4M Ascorbate E) Experimental 3 Alginate+ HNTs+ BMP 4 F) 
Experimental 4 Alginate+ HNTs+ BMP 6.
In Figure 4-1, A) and B) are controls with alginate hydrogels without HNTs as in 
A and without growth factors as in B. Figures 4-1 C), D), E), and F) show alginate+ 
HNTs+ BMP 2, alginate+ HNTs+ BMP 2 with 0.4 M ascorbate added to the medium, 
alginate+ HNTs+ BMP 4 and alginate+ HNTs+ BMP 6, respectively. Day 0 staining was 
done after 8 hours of osteoblast encapsulation with the hydrogels. The images show that 
C and D have more proliferating cells as seen by the pink Hematoxylin stained nuclei. 
Images E and F are comparable to the controls in A and B. No pink stained masses were 
visible in the images A, B, E, and F. This suggests that proliferation was slower in these 
hydrogels as compared to the images in C and D after 8 hours of cell encapsulation. 
Figure 4-2 (A-F) shows Alcian Blue on Day 7.
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Figure 4-2. Alcian Blue staining Day 7 A) Control 1 Alginate-only B) Control 2 Alginate 
+ HNTs C) Experimental 1 Alginate+ HNTs+ BMP 2 D) Experimental 2 Alginate+ 
HNTs+ BMP 2 with 0.4M Ascorbate E) Experimental 3 Alginate+ HNTs+ BMP 4 F) 
Experimental 4 Alginate+ HNTs+ BMP 6.
In Figure 4-2, controls A and B show less to no deep stained islands or patches of 
differentiated cells. The staining looks lighter in the controls A and B unlike the 
experimental groups (C-F). Experimental groups #1 and #2 (C and D) show pink and 
blue areas with deep pink stained islands or patches of differentiating cells shown by the 
arrows. Experimental groups #3 and #4 (E and F) show deeply stained hydrogels 
suggesting that the ECM produced was more and evenly spread than the rest of groups. E 
and F also show some dark pink spots or deeply stained patches which are cells
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concentrated in these areas shown by arrows. A comparison of the images, C, D, E, and F 
with the controls A and B, suggests that the experimental groups performed better with 
respect to the ECM production (which is suggestive of cellular differentiation) by Day 7. 
The images E and F when compared to C and D show prominent dark patches of cells 
surrounded by ECM mucopolysachharides that is evenly spread throughout the hydrogels 
suggesting that experimental groups #3 and #4 performed better with to respect to ECM 
production than experimental groups #1 and #2. Figure 4-3 (A-F) shows Alcian Blue 
staining on Day 14.
t
Figure 4-3. Alcian Blue staining Day 14 A) Control 1 Alginate-only B) Control 2 
Alginate + HNTs C) Experimental 1 Alginate+ HNTs+ BMP 2 D) Experimental 2 
Alginate+ HNTs+ BMP 2 with 0.4M Ascorbate E) Experimental 3 Alginate+ HNTs+ 
BMP 4 F) Experimental 4 Alginate+ HNTs+ BMP 6.
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In Figure 4-3, controls A and B show light pink (cells) and blue regions (stained 
ECM) suggesting differentiating cells surrounded by the ECM they secrete. The staining 
is lighter than the experimental groups #l-#4 (images C-F). The experimental groups #1 
and #2 (C and D) show dark pink patches shown by arrows (differentiating osteoblasts) 
surrounded by dark blue regions of dense ECM mucopolysachharides. The experimental 
groups #3 and #4 (E and F) show larger dark pink or purple patches of the differentiating 
cells surrounded by dark blue stained ECM mucopolysachharides. The images in Figure 
4-3 (A-F) show that even though the controls (A and B) have started showing blue 
stained ECM, it is much lighter than the experimental groups #l-#4 (C-F). The 
experimental groups #3 and #4 (E and F) show darker and deeper blue stained hydrogels 
than the experimental #1 and #2 (C and D) suggesting more ECM is produced in these 
hydrogels than the other on Day 14. Figure 4-4 (A-F) shows Alcian Blue staining on Day 
21 .
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Figure 4-4. Alcian Blue staining Day 21 A) Control 1 Alginate-only B) Control 2 
Alginate + HNTs C) Experimental 1 Alginate+ HNTs+ BMP 2 D) Experimental 2 
Alginate+ HNTs+ BMP 2 with 0.4M Ascorbate E) Experimental 3 Alginate+ HNTs+ 
BMP 4 F) Experimental 4 Alginate+ HNTs+ BMP 6.
In Figure 4-4, controls A and B show deep pink or purple patches of cells 
surrounded by ECM stained in blue. The experimental groups #l-#4 (C-F) show deeper 
pink stained regions and dark blue stained regions of ECM as compared to the controls A 
and B. The experimental groups #1 and #2 (C and D) show the dark pink or purple 
regions of cells, shown by arrows, surrounded by blue colored region of ECM produced 
by these cells. The experimental groups #3 and #4 (E and F) show dark patches of cells, 
shown by arrows, surrounded by deep blue stained ECM. The images E and F show 
hydrogels stained blue and no differentiable pink regions because the ECM 
mucopolysachharides are denser than the other groups.
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If the images of the experimental groups #l-#4 (C-F) from day 0 to Day 21 are 
compared, experimental groups #3 and #4 (E and F) show deep blue stained hydrogels 
from day 0 to Day 21 suggesting that the hydrogels with BMP 4 and 6 loaded HNTs 
perform better with respect to the early onset of ECM production by the differentiating 
cells. The experimental group 2 (D) showed more deep pink patches of the cells on Day 7 
and the trend continues till Day 21. The deep pink patches are surrounded by deep blue 
stained regions of ECM mucopolysachharides, well defined on days 14 and 21. This 
suggests that hydrogels with BMP 2 loaded HNTs combined with 0.4 M ascorbate in 
growth medium enhanced cellular proliferation and differentiation.
The control 2 with alginate+ HNTs and no growth factors (B) showed no 
enhancement of cellular responses in the hydrogels on days 0 to 21 suggesting that 
halloysite, alone, would not enhance the cellular responses in these hydrogels. To achieve 
enhanced cellular response for nanoenhanced hydrogels, the HNTs should be loaded with 
osteogenic growth factors such as the ones used in this project, namely, BMP 2 ,4, and 6.
The observations made by visual qualitative analysis of the Alcian Blue stained 
sections of hydrogels can be further ascertained by image analysis done by Image J 
software. The representative images of Controls 1 & 2 and the experimental groups E l, E 
3, and E4 for days 0 and 21 are given in Figure 4-5 to 4-15. Figure 4-5 shows RGB peaks 
for alginate-only hydrogel control (Cl) for day 0.
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Figure 4-5. Image analysis for Alcian Blue staining Control 1 Day 0.
Figure 4-5 shows the RGB peaks for Alcian Blue staining for control 1 on day 0. 
The intensity for Blue and Red is towards the value 255 which is for white color. It 
implies that the Blue and Red are less intense in the given region of interest. This 
supports the observation from the qualitative visual analysis o f the histological staining 
earlier suggesting less cell proliferation and low ECM production in the control 1 on day 
0. Figure 4-6 shows RGB peaks for alginate-only hydrogel control (C l) for Day 21.
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Figure 4-6. Image analysis for Alcian Blue staining Control 1 Day 21.
Figure 4-6 shows RGB peaks for Alcian Blue staining for control 1 on Day 21. 
The intensity for Blue falls in the range between the values 0 which is for Black and 255 
which is for white color. This suggests that there is some production of ECM in the 
hydrogel matrix as observed in the earlier section on the histological analysis. The 
intensity for red falls near black suggesting more intense red staining indicating presence 
of proliferated cells. This observation supports the observations in the previous section 
suggesting that alginate-only hydrogels showed more cellular proliferation by Day 21 and 
very little ECM production. Figure 4-7 shows RGB peaks for alginate + HNTs hydrogel 
control (C2) for day 0.
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Figure 4-7. Image analysis for Alcian Blue staining Control 2 Day 0.
Figure 4-7 shows the RGB peaks for Alcian Blue staining for control 2 on day 0. 
The red color has intensity falling midway between the values for black color (0) and 
white color (255). Green and blue have intensities closer to white color suggesting a less 
intense staining. This suggests that the Red color is more intense in the region of interest 
suggesting more cell proliferation. This supports the observations in the previous section 
that control 2 has more cell proliferation and less ECM production. Figure 4-8 shows 
RGB peaks for alginate + HNTs hydrogel control (C2) for Day 21.
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Figure 4-8. Image analysis for Alcian Blue staining Control 2 Day 21.
Figure 4-8 shows Alcian Blue staining for control 2 on Day 21. The red color 
shows intensity ranging over a broad range of values lying midway between the values 
for black (0) and white (255). This suggests that there is increased cell proliferation seen 
in the region of interest. The blue and green colors have intensity values at the midway 
but more towards black. This suggests that there is slight increase in the ECM production 
from day 0. This is supported by the observations in the earlier section suggesting that 
when compared to control 1 and day 0 there was slight increase in ECM production in
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control 2 on Day 21. Figure 4-9 shows RGB peaks for Alginate + HNTs + BMP 2 
hydrogel experimental (El) for day 0.
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Figure 4-9. Image analysis for Alcian Blue staining Experimental 1 Day 0.
Figure 4-9 shows RGB peaks for Alcian Blue staining of experimental 1 on day 0. 
All the three colors show peaks that are well pronounced and lie slightly towards black. 
This suggests that there is fair amount of cell proliferation and some ECM production in 
the experimental 1 on day 0. This observation is also substantiated in the earlier section. 
Figure 4-10 shows RGB peaks for alginate + HNTs + BMP 2 hydrogel experimental (El) 
for Day 21.
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Figure 4-10. Image analysis for Alcian Blue staining Experimental 1 Day 21.
Figure 4-10 shows RGB peaks for Alcian Blue staining for experimental 1 on Day 
21. All the three colors show broad range of values for intensities. Especially red that 
ranges from value near black (0) to white (255). This suggests that there is more cell 
proliferation as well as ECM production suggested by the intense staining in red and 
blue. Figure 4-11 shows RGB peaks for alginate + HNTs + BMP 4 hydrogel 
experimental (E3) for day 0.
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Figure 4-11. Image analysis for Alcian Blue staining Experimental 3 Day 0.
Figure 4-11 shows RGB peaks for Alcian Blue staining for experimental 3 on day 
0. There is an intense red staining suggested by the sharp red peak falling on the value 0 
for black color. There is very less intense blue color suggested by the blue peak lying on 
the value 255 for white color. This suggests that there is cell proliferation but little to no 
ECM production. Figure 4-12 shows RGB peaks for alginate + HNTs + BMP 4 hydrogel 
experimental (E3) for Day 21.
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Figure 4-12. Image analysis for Alcian Blue staining Experimental 3 Day 21.
Figure 4-12 shows RGB peaks for Alcian Blue staining for experimental 3 on Day 
21. As seen in the graph for red color the peak shows intense red staining suggesting a 
high cell proliferation. The blue color also has intensity increased from day 0 suggesting 
increased ECM production. These observations are supported by the observations made 
in the previous section that the ECM production increased as the days progressed in 
experimental 3. Figure 4-13 shows RGB peaks for alginate + HNTs + BMP62 hydrogel 
experimental (E4) for day 0.
56
i  E4.D0.AB.jpg 
>29x278 pawls; ROB; 468K
□  X  i  RcdHistogrwnofEA.DO.AB
300x240 pixels; ROB; 281K
i  Green Histogram of E4.D0.AB 
300x240 pixels; ROB; 281K
255
Count 17756 
Mean: 4.375 
StdDev; 3 939
MinO 
Max; 21
Mode: 0 (3764)
U st| Copy[ Log | Lfve | [RGb|
q  x  i  Blue Hntognm of E4.D0.AB — □
300x240 pixels; ROB; 281K__________________
255
Count 17756 
Mean: 63 434 
StdDev 5.396
Min: 46 
Max: 82
Mode: 65 (1386)
Count 17756 Min: 174
Mean: 236.085 Max: 255
StdDev 15.193 Mode: 255 (2131)
List Copy Log UvollRGB
value-241
count-0
Ust Copy Log live 11 RGB
I
Figure 4-13. Image analysis for Alcian Blue staining Experimental 4 Day 0.
Figure 4-13 shows RGB peaks for Alcian Blue staining for experimental 4 on day 
0. Red has more intense staining in the region of interest suggesting high cell 
proliferation and blue has very less intensity suggesting little ECM production on day 0. 
This observation is supported in the previous section which showed little ECM 
production in the experimental 4 on day 0. Figure 4-14 shows RGB peaks for alginate + 
HNTs + BMP62 hydrogel experimental (E4) for Day 21.
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Figure 4-14. Image analysis for Alcian Blue staining Experimental 4 Day 21.
Figure 4-14 shows RGB peaks for Alcian Blue staining for experimental 4 on 
Day 21. The red has intense staining but it has reduced since day 0 and the intensity for 
blue has increased suggesting retardation in the cell proliferation and increase in ECM 
production supported by the observations in the previous section suggesting an increase 
in the ECM production since day 0 in experimental 4.
These representative image analysis results support the earlier observations made 
suggesting that the addition of HNTs and BMPs 2,4, and 6 improved ECM production 
and emhanced cellular differentiation in these constructs when compared to the controls 1 
and 2 form days 0 to 21.
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4.3.1.2 Picrosirius Red staining. The Picrosirius Red staining helps to visualize the
collagen secreted by the differentiating cells as a result of laying foundation of the new 
tissue. Collagen is the most abundant substance in connective tissues. [45] It gives the 
tissues their elasticity and maintains their structural integrity. [45] Figures 4-5 to 4-8 
show the Picrosirius Red staining of the alginate hydrogels enhanced with BMP 2,4, 
and 6 loaded HNTs with osteoblasts encapsulated in them for days 0, 7,14, and 21. The 
figures are representative and show the days that highlight the trend of progression of 
differentiation and production of collagen as a part of new tissue formation. Figure 4-15 
(A-F) shows the Picrosirius Red staining for day 0.
Figure 4-15. Picrosirius Red staining Day 0 A) Control 1 Alginate-only B) Control 2 
Alginate + HNTs C) Experimental 1 Alginate+ HNTs+ BMP 2 D) Experimental 2 
Alginate+ HNTs+ BMP 2 with 0.4M Ascorbate E) Experimental 3 Alginate+ HNTs+ 
BMP 4 F) Experimental 4 Alginate+ HNTs+ BMP 6.
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In Figure 4-15, Controls 1 and 2 (A and B) show dark spots of cells. Control 2 (B) 
shows deeper staining as compared to control 1 (A). Experimental groups 1, 2, 3, and 4 
(C-F) show dark patches of cells surrounded by red stained gel matrix containing 
collagen. Experimental 2 (D), shows larger cell patches suggesting that more cells 
proliferated compared to the other experimental groups, (C, E, and F). The experimental 
groups 1 and 2 show deep red staining suggesting that the collagen secretion was more 
compared to the experimental groups 3 and 4 (E and F). Figure 4-16 (A-F) shows 
Picrosirius Red staining for Day 7.
B)
Figure 4-16. Picrosirius Red staining Day 7 A) Control 1 Alginate-only B) Control 2 
Alginate + HNTs C) Experimental 1 Alginate+ HNTs+ BMP 2 D) Experimental 2 
Alginate+ HNTs+ BMP 2 with 0.4M Ascoibate E) Experimental 3 Alginate+ HNTs+ 
BMP 4 F) Experimental 4 Alginate+ HNTs+ BMP 6.
In Figure 4-16, Controls 1 and 2 (A and B) show dark spots of proliferated cells
and collagen which is stained in red. The amount of collagen that is produced by the cells
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is more compared to Day 0. Experimental groups #1,2, 3, and 4 (C-F) show more 
proliferation of the cells as dark patches are more numerous compared to Day 0. 
Experimental groups #2, 3, and 4 (D, E, and F) show deeper staining with Picrosirius Red 
suggesting more collagen production as the days advance. The staining of the 
experimental groups #2, #3, and #4 (D, E, and F) is darker than the controls indicating 
that the hydrogels with BMP 2 and ascorbate, BMP 4 and BMP 6 were performing better 
with respect to collagen secretion against the controls. Figure 4-17 (A-F) shows 
Picrosirius Red staining for Day 14.
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Figure 4-17. Picrosirius Red staining Day 14 A) Control 1 Alginate-only B) Control 2 
Alginate+ HNTs C) Experimental 1 Alginate+ HNTs+ BMP 2 D) Experimental 2 
Alginate+ HNTs+ BMP 2 with 0.4M Ascorbate E) Experimental 3 Alginate+ HNTs+ 
BMP 4 F) Experimental 4 Alginate+ HNTs+ BMP 6.
In Figure 4-17, controls 1 and 2 (A and B) show deep red staining compared to 
days 0 and 7. The experimental groups #1, #2, #3, and #4 (C-F) show deeper staining
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with experimental groups #3 and #4 (E and F) showing a uniform and dark staining. This 
suggests that as the days progressed, collagen production increased with collagen 
secretion being more uniformly distributed in experimental groups #3 and #4 (E and F). 
Experimental groups #1 and #2 (C and D) show more dark patches of cell compared to 
group #3 and #4 (E and F). Based on the deep stained gel matrix in experimental groups 
#3 and# 4, it can be inferred that the cell patches were not visible because of larger 
amounts of collagen being produced by the differentiating cells. Figure 4-18 shows 
Picrosirius Red staining for Day 21.
Figure 4-18. Picrosirius Red staining Day 21 A) Control 1 Alginate-only B) Control 2 
Alginate + HNTs C) Experimental 1 Alginate+ HNTs+ BMP 2 D) Experimental 2 
Alginate+ HNTs+ BMP 2 with 0.4M Ascorbate E) Experimental 3 Alginate+ HNTs+ 
BMP 4 F) Experimental 4 Alginate+ HNTs+ BMP 6.
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In Figure 4-18, controls 1 and 2 (A and B) show lighter staining compared to 
experimental groups #l-#4 (C-F). A comparison of all the groups reveals that the 
collagen production is at its peak on Day 7. The experimental group #4 (F) shows the 
most collagen amongst all the groups (A-E) on Day 21. All the experimental groups show 
large cell patches surrounded by collagen they produced.
Comparison of the experimental groups #l-#4 (C-F) with controls 1 and 2 (A and 
B) throughout all days, suggests that there was a marked difference in the cellular 
response with respect to collagen production by the experimental groups. The cellular 
proliferation and differentiation was more compared to the experimental groups on all 
days except Day 7. The difference in the collagen production by the experimental groups 
throughout the 21-day period might be the influence of the growth factors (BMP 2,4, and 
6) loaded in HNTs. There was also an early onset o f collagen production on Day 0 (8 
hours after cellular encapsulation in the hydrogels) in the experimental groups suggesting 
collagen production starts early in the hydrogels with growth factor loaded HNTs against 
the controls. This may be important as it would trigger faster bone regeneration by 
enhanced and early cell differentiation response.
The observations made by visual qualitative analysis of the Picrosirius Red 
stained sections of hydrogels can be further ascertained by image analysis done by Image 
J software. The representative images of Controls 1 & 2 and the experimental groups E l, 
E 3, and E4 for days 0 and 21 are given in Figure 4-19 to 4-28. Figure 4-19 shows RGB 
peaks for alginate-only hydrogel control (C l) for day 0.
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Figure 4-19. Image analysis for Picrosirius Red staining for Control 1 Day 0.
Figure 4-19 shows RGB peaks for Picrosirius Red staining for control 1 on day 0. 
The intensity for red color is less as can be seen in the graph for red color. The colors 
green and blue show intensities of similar values suggesting that not much red stain 
present in the region of interest which means that the collagen production is very less. 
This is expected on day 0 of the staining and is also supported in the observations made 
in the earlier sections. Figure 4-20 shows RGB peaks for alginate-only hydrogel control 
(Cl) for Day 21.
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Figure 4-20. Image analysis for Picrosirius Red staining for Control 1 Day 21.
Figure 4-20 shows RGB peaks for Picrosirius Red staining for control 1 on Day 
21. The red color has a very low intensity and the colors blue and green are more intense. 
This suggests that the cellular proliferation is more and collagen production is very less in 
control 1 on Day 21. This observation is supported by the observations in the previous 
section suggesting that the collagen production remains low in control 1 on Day 21. 
Figure 4-21 shows RGB peaks for alginate + HNTs hydrogel control (C2) for day 0.
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Figure 4-21. Image analysis for Picrosirius Red staining for Control 2 Day 0.
Figure 4-21 shows Picrosirius Red staining for control 2 on day 0. All the three 
colors show intense staining in the section and this might be due to the section being 
thick and appearing darker. The high intensity o f red in this section does not suggest high 
collagen production. This inference can be drawn by taking into consideration other 
constructs and the behavior of control 2 over advancing days. Figure 4-22 shows RGB 
peaks for alginate + HNTs hydrogel control (C2) for Day 21.
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Figure 4-22. Image analysis for Picrosirius Red staining for Control 2 Day 21.
Figure 4-22 shows RGB peaks for Picrosirius Red staining for control 2 on Day 
21. The red color shows less intense staining and this suggests less collagen production 
over a period of 21 days. This observation can also be supported by looking at the 
previous section images for control 2 for 21 day period. Figure 4-23 shows RGB peaks 
for alginate + HNTs + BMP 2 experimental (El) for day 0.
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Figure 4-23. Image analysis for Picrosirius Red staining for Experimental 1 Day 0.
Figure 4-23 shows RGB peaks for Picrosirius Red staining for experimental 1 on 
day 0. The peak for red shows a lot of noise and this might be due to the section being 
uneven. The intensity for red is still higher than the controls 1 and 2 on day 0. This 
suggests that the collagen production has already started in the experimental 1 on day 0. 
This observation supports the inference from the previous section that there is early onset 
of cellular differentiation in the experimental set 1. Figure 4-24 shows RGB peaks for 
alginate + HNTs + BMP 2 experimental (El) for Day 21.
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Figure 4-24. Image analysis for Picrosirius Red staining for Experimental 1 Day 21.
Figure 4-24 shows RGB peaks for Picrosirius Red staining for experimental 1 on 
Day 21. The region of interest here is a dense patch which might be cellular mass 
secreting collagen. The high red intensity might indicate high collagen secretion. The 
intensities are also high for green and blue colors and that might be due to the thick mass. 
The observations are in congruence with the observations from the previous section 
suggesting high collagen production in experimental 1 for a 21 day period. Figure 4-25 
shows RGB peaks for alginate + HNTs + BMP 4 experimental (E3) for day 0.
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Figure 4-25. Image analysis for Picrosirius Red staining for Experimental 2 Day 0.
Figure 4-25 shows RGB peaks for Picrosirius Red staining for experimental 2 on 
day 0. There is a high intensity blue color and also a pronounced green color for the 
region of interest. The red color has the least intensity suggesting that the collagen 
secretion is low on day 0. The different intensity values for green and blue colors might 
be due to the uneven sectioning. Figure 4-26 shows RGB peaks for alginate + HNTs + 
BMP 4 experimental (E3) for Day 21.
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Figure 4-26. Image analysis for Picrosirius Red staining for Experimental 3 Day 21.
Figure 4-26 shows RGB peaks for Picrosirius Red staining for experimental 3 on 
Day 21. The intensity for green is high and red also has relatively higher intensity 
suggesting an increased collage production over 21 day period. This observation is 
supported by the observations in the previous section that the collagen production in 
experimental 3 increased from day 0 to Day 21. Figure 4-27 shows RGB peaks for 
alginate + HNTs + BMP 6 experimental (E4) for day 0.
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Figure 4-27. Image analysis for Picrosirius Red staining for Experimental 4 Day 0.
Figure 4-27 shows RGB peaks for Picrosirius Red staining for experimental 4 on 
day 0. The region of interest shows a red colored dense patch however, the red color has 
low intensity as can be seen in the graph for red. The intensities are high for green and 
blue suggesting the density of the region being high. This might be due to sectioning or 
due to collagen deposition. A high intensity green staining for Picrosirius Red is also an 
indicator for deposition of collagen type III. But it needs further investigation to find out 
which type of collagen is being deposited in the hydrogel matrix. Figure 4-28 shows 
RGB peaks for alginate + HNTs + BMP 6 experimental (E4) for Day 21.
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Figure 4-28. Image analysis for Picrosirius Red staining for Experimental 4 Day 21.
Figure 4-28 shows RGB peaks for Picrosirius Red staining for experimental 4 on 
Day 21. The region of interest shows intensity for red is scattered and it might be due to 
an uneven section or presence of dense bodies of cellular material. The intensities for 
green and blue are also high and this might be indication of presence of dense material in 
die selected area. This observation is supported by the observations in the previous 
section suggesting high amount of collagen being secreted in the cellular clusters forming 
dense bodies.
The observations from the image analysis for Picrosirius red stain suggest that the 
experimentals 1,3, and 4 performed better with respect to collagen secretion and also 
there was an increase in the collagen secretion as the days advanced from 0 to 21. It can
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be inferred that the addition of HNTs loaded with growth factors like BMP 2,4, and 6 
enhanced cellular differentiation in the hydrogel constructs.
4.3.1.3 Von Kossa stainim. The Von Kossa stain is 5% v/v silver nitrate which 
reacts with the phosphate group of calcium phosphate which is the mineral component 
of bone. Calcium phosphate is secreted by the cells during differentiation. Figures 4-29 
to 4-32 (A-F) show Von Kossa staining of the alginate hydrogels for days 0 to 21. 
Figure 4-29 (A-F) shows the Von Kossa staining for Day 0.
Figure 4-29. Von Kossa staining Day 0 A) Control 1 Alginate-only B) Control 2 
Alginate + HNTs C) Experimental 1 Alginate+ HNTs+ BMP 2 D) Experimental 2 
Aiginate+ HNTs+ BMP 2 with 0.4M Ascorbate E) Experimental 3 Alginate+ HNTs+ 
BMP 4 F) Experimental 4 Alginate+ HNTs+ BMP 6.
Day 0 shows the staining done after 8 hours of encapsulating the cells in 
hydrogels. Figure 4-29 (A-F) shows that the cells have not started their differentiation in
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any of the control or experimental groups. This is because the initial stage for the cells is 
to establish anchorage in the matrix and then to produce ECM for cellular communication 
for differentiation.
Figure 4-30. Von Kossa staining Day 7 A) Control 1 Alginate-only B) Control 2 
Alginate + HNTs C) Experimental 1 Alginate+ HNTs+ BMP 2 D) Experimental 2 
Alginate+ HNTs+ BMP 2 with 0.4M Ascorbate E) Experimental 3 Alginate+ HNTs+ 
BMP 4 F) Experimental 4 Alginate+ HNTs+ BMP 6.
In Figure 4-30, the controls 1 and 2 (A and B) show small areas of black-brown 
coloration which are calcium phosphate deposits stained with Von Kossa. The 
experimental groups (C-F) show larger brown-black patches of calcium phosphate 
deposits stained with Von Kossa. Once the osteoblasts have proliferated and established 
connections with each other they start differentiating and produce substances which lay 
foundation of new bone such as calcium phosphate. Usually this process starts by Day 7.
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The images of the experimental groups (C-F) show the progression of deposition of 
calcium phosphate by the differentiating cells. Amongst the experimental groups the 
groups #1 and #3 (C and E) show distinct black depositions of calcium phosphate shown 
by arrows.
Figure 4-31. Von Kossa staining Day 14 A) Control 1 Alginate-only B) Control 2 
Alginate + HNTs C) Experimental 1 Alginate+ HNTs+ BMP 2 D) Experimental 2 
Alginate+ HNTs+ BMP 2 with 0.4M Ascorbate E) Experimental 3 Alginate+ HNTs+ 
BMP 4 F) Experimental 4 Alginate+ HNTs+ BMP 6.
Figure 4-31 (A-F) shows the progression of calcium phosphate deposition by the 
differentiating osteoblasts on Day 14. The cells have formed distinct deposits of calcium 
phosphate seen in all the groups (controls and experimental) as brown-black patches. 
From the images it can be inferred that the deposition of calcium phosphate in the 
hydrogel matrix is more pronounced on Day 14 than the onset of differentiation (Day 7).
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The experimental groups #3 and #4 (C and D) have more depositions than the controls or 
experimental groups #1 and #2 (seen as deeply stained hydrogel matrix without distinct 
patches).
Figure 4-32. Von Kossa staining Day 21 A) Control 1 Alginate-only B) Control 2 
Alginate + HNTs C) Experimental 1 Alginate+ HNTs+ BMP 2 D) Experimental 2 
Alginate+ HNTs+ BMP 2 with 0.4M Ascorbate E) Experimental 3 Alginate+ HNTs+ 
BMP 4 F) Experimental 4 Alginate+ HNTs+ BMP 6.
Figure 4-32 (A-F) shows the progression of calcium phosphate deposition on Day 
21. Compared to the controls 1 and 2 (A and B) the experimental groups (C-F) have more 
calcium phosphate deposition. Amongst all the experimental groups, experimental groups 
#3 and #4 (E and F) have the most pronounced deposition seen as deeply stained 
hydrogel matrix.
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Comparing the images of Von Kossa staining, the controls and the experimental 
groups through the 21-day period show that the deposition of calcium phosphate starts on 
Day 7 and is more in the experimental groups #3 and #4 (E and F). This suggests that the 
hydrogels having BMP 4 and 6 loaded HNTs perform better with respect to other groups.
The observations made by visual qualitative analysis of the Von Kossa stained 
sections of hydrogels can be further ascertained by image analysis done by Image J 
software. The representative images of Controls 1 & 2 and the experimental groups E l, E 
3, and E4 for days 0 and 21 are given in Figure 4-33 to 4-42. Figure 4-33 shows 
Grayscale intensity for alginate-only hydrogel control (Cl) for day 0.
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Figure 4-33. Grayscale intensity for Von Kossa staining for Alginate-only hydrogel 
control 1 (Cl) for Day 0.
Figure 4-33 shows grayscale intensity for Von Kossa staining for control 1 on day 
0. The grayscale intensity value will show how dark was the staining in the region of 
interest suggesting increased or slight mineral deposition of hydroxyapatite crystals. The 
grayscale graph shows less intense staining suggesting that the mineral deposition was 
not much on day 0 for control 1. Figure 4-34 shows Grayscale peak for alginate-only 
hydrogel control (Cl) for Day 21.
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Figure 4-34. Grayscale intensity for Von Kossa staining for Alginate-only hydrogel 
control 1 (C l) for Day 21.
Figure 4-34 shows grayscale intensity for Von Kossa staining for control 1 on 
Day 21. The grayscale graph does not show much change in the intensity for the stain 
suggesting that there was not much mineralization in the control 1 hydrogel matrix after 
21 day period. Figure 4-35 shows Grayscale peak for alginate + HNTs hydrogel control 
(C2) for day 0.
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Figure 4-35. Grayscale intensity for Von Kossa staining for Alginate + HNTs hydrogel 
control 2 (C2) for Day 0.
Figure 4-35 shows grayscale intensity for Von Kossa staining for control 2 on day 
0. The intensity of the stain is less on day 0 for control 2 suggesting that the
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mineralization has not yet started. Figure 4-36 shows Grayscale peak for alginate + HNTs 
hydrogel control (C2) for Day 21.
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Figure 4-36. Grayscale intensity for Von Kossa staining for Alginate + HNTs hydrogel 
control 2 (C2) for Day 21.
Figure 4-36 shows grayscale intensity for Von Kossa staining for control 2 on 
Day 21. The intensity for the staining has increased from day 0 suggesting mineralization 
and calcium phosphate deposition. This observation is supported by the obsevations in 
the previous section. Figure 4-37 shows Grayscale peak for alginate + HNTs + BMP 2 
experimental (El) for day 0.
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Figure 4-37. Grayscale intensity for Von Kossa staining for Alginate + HNTs + BMP 2 
experimental 1 (El) for Day 0.
Figure 4-37 shows grayscale intensity for Von Kossa staining for experimental 1 
on day 0. The intensity for the stain can be compared to the day 0 values of controls 1 and 
2. The intensity is low for the staining suggesting that the mineralization has not yet 
started on day 0. Figure 4-38 shows Grayscale peak for alginate + HNTs + BMP 2 
experimental (E l) for Day 21.
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Figure 4-38. Grayscale intensity for Von Kossa staining for Alginate + HNTs + BMP 2 
experimental 1 (E1) for Day 21.
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Figure 4-38 shows the grayscale intensity for Von Kossa staining for 
experimental 1 on Day 21. The grayscale intensity for the region of interest shows an 
increase suggesting that there is mineralization and it is more than that of the controls 1 
and 2 on Day 21. Figure 4-39 shows Grayscale peak for alginate + HNTs + BMP 4 
experimental (E3) for day 0.
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Figure 4-39. Grayscale intensity for Von Kossa staining for Alginate + HNTs + BMP 4 
experimental 3 (E3) for Day 0.
Figure 4-39 shows grayscale intensity for Von Kossa for experimental 3 on day 0. 
The graph for the grayscale shows low intensity o f staining suggesting that the 
mineralization has yet to start. Figure 4-40 shows Grayscale peak for alginate + HNTs + 
BMP 4 experimental (E3) for Day 21.
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Figure 4-40. Grayscale intensity for Von Kossa staining for Alginate + HNTs + BMP 4 
experimental 3 (E3) for Day 21.
Figure 4-40 shows grayscale intensity for Von Kossa for experimental 3 on Day 
21. The graph for the grayscale shows a very high intensity value for the region of 
interest. It suggests that the region of interest has calcium phosphate deposits indicating 
mineralization. The increase in the mineralization from day 0 to 21 and also a comparable 
increase in the mineral deposition against controls 1 and 2 is supported by the 
observations in the previous section. Figure 4-41 shows Grayscale peak for alginate + 
HNTs + BMP 6 experimental (E4) for day 0.
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Figure 4-41. Grayscale intensity for Von Kossa staining for Alginate + HNTs + BMP 6 
experimental 4 (E4) for Day 0.
Figure 4-41 shows grayscale intensity for Von Kossa for experimental 4 on day 0. 
There is noise in the grayscale graph which might be due to uneven sectioning but the 
overall value is comparable to the controls 1 and 2 on day 0. This suggests that the 
mineralization has not yet started for experimental 4 on day 0. Figure 4-42 shows 
Grayscale peak for alginate + HNTs + BMP 6 experimental (E4) for Day 21.
£ E4.D21.VK.jpg 
432x304 pixel*; ROB; 513K
X  £  Histogram of E4.D21.VK 
300x240 pixel*; ROB; 281K
D
C ount 14000 
Mean: 60.646 
StdOev. 18.561
255
Min: 8 
Max: 138 
Mode: 41 (409)
U»t | Copy | Log I Uve I [RGB I
velue-62 
count*225
Figure 4-42. Grayscale intensity for Von Kossa staining for Alginate + HNTs + BMP 6 
experimental 4 (E4) for Day 21.
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Figure 4-41 shows grayscale intensity for Von Kossa for experimental 4 on Day 
21. There is noise in the graph which might be due to uneven sectioning or high mineral 
deposits but the overall intensity for the staining has increased. This indicates high 
mineral deposition in the experimental 4 matrix on Day 21. It can be inferred taking into 
consideration the image analysis for Von Kossa that the experimental 1,3, and 4 
performed better with respect to the mineralization. The addition of HNTs and BMPs 2,
4, and 6 enhanced die mineralization promoted cellular differentiation in the respective 
hydrogel constructs.
Comparing all the three histochemical staining images (Alcian Blue, Picrosirius 
Red, and Von Kossa, Figures 4-29 to 4-32) a progression of events can be visualized. The 
ECM production starts early (Day 7) in experimental groups #3 and #4 (hydrogels with 
BMP 4 and 6 loaded HNTs). The experimental groups #3 and #4 also show early onset of 
collagen production (Day 0 ,8  hours after cell encapsulation). In the case o f Von Kossa 
staining, the experimental groups #3 and #4 have the most calcium phosphate deposition 
on Day 7 amongst all the four experimental groups.
The observations from all the three histochemical staining analyses suggest that 
experimental groups #3 and #4 performed better with respect to early onset of 
differentiation of osteoblasts. The experimental groups #1 and #2 performed better 
compared to the controls 1 and 2 with respect to differentiation of osteoblasts (production 
of ECM, collagen and calcium deposition). The results from the histochemical analyses 
suggest that the hydrogel enhanced with growth factors loaded Halloysite perform better 
than the control hydrogels of calcium alginate and calcium alginate+ HNTs. This is also 
substantiated by the image analysis of the histochemical staining images by Image J
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software which showed that there was indeed an increase in ECM and collagen 
production and mineral deposition in experimental sets 1, 3, and 4.
4.3.2 Release Profile Study of BMP 2 from HNTs
The release profile study of BMP 2 from HNTs was measured with custom made 
sandwich ELISA kits, to estimate the amount of BMP 2 eluted out of the HNTs over a 
period of 24 hours and 7 days. This measurement was done to investigate if the amount 
of growth factor eluted from the HNTs was similar to the amount secreted in the body 
and to mimic the natural internal environment. Figure 4-43 is the calibration curve for the 
ELISA kit with known standards.
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Figure 4-43. Calibration curve for BMP 2 standards.
Absorbance is on the Y-axis and concentrations of the standard is on X-axis. 
Figure 4-44 shows the conversion plot for absorbance to log concentrations used to 
calculate BMP 2 release, y  = O.OOOSx + 0.0561.
y = 0.0005x + 0.0561,
86
Optical Density
2.5
c
„ 1.5u
0
2
y = 1.265!
Linear (OD)
-0.5
0 1 2
Log Concentration
3 4
Figure 4-44. Graph showing conversion of absorbance to log concentrations.
Figure 4-45 shows the trend of BMP 2 release from HNTs for a period of 24 
hours. The release was achieved by the vacuum loaded HNTs in HBSS at room 
temperature. The amount of BMP 2 release was estimated by sandwich ELISA and 
reading the plate on absorbance plate reader. The experiment was repeated thrice to 
reduce error and to check for the reproducibility of results. The values are the means of 
the readings of BMP 2 from HNTs at the respective time points recorded from the three 
repetitions of the experiment. The error bars reflect the standard deviation at each data 
point calculated by standard deviation and the average of the triplicate samples (detailed 
process of calculation of the standard deviation described in Appendix B). [59]
87
Release of BMP-2 (24 hours)
250 i
200
150E
au
o  ioo
50
f
-  Release Concentration
0 1 2 3 4 5 6 7 8 9
Sample Points
Figure 4-45. Release profile of BMP 2 from HNTs for 24 hours.
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The graph shows a sustained release of the growth factor for 24 hours in the range 
of picograms per ml which is comparable to the range the growth factors are secreted in 
the body. [54] HNTs are cylindrical in shape with the inner lumen comprising of 
concentric layers of aluminosilicate. When any drug or bioactive agent is vacuum-loaded 
into the HNTs, the molecules become trapped in both the lumen and the outer surface. 
Before starting the release study of BMP 2 we washed the sample of loaded HNTs with 
distilled water twice to remove the BMP 2 coated on the outer surfaces o f the HNTs. It 
cannot be guaranteed that all the molecules are removed during the washing step as can 
be seen in the initial burst release of BMP 2 within first one hour of the study. The trend 
seen here is not of the cumulative release but that of individual data points. The 
concentration seen in the graph cannot be regarded as accurate estimate as the standards 
provided by the manufacturer showed resolution problems. The data should be viewed
8 8
cautiously and regarded as a qualitative estimate of the protein released from the HNTs. 
The raw data tables and supplementary tables are provided in Appendix B.
The graph of the release profile study for BMP 2 from HNTs for 7 days is given 
in the Figure 4-46. The calibration curves in Figures 4-43 and 44 were used to the 
calculations in the plotting of graph in Figure 4-46.
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Figure 4-46. The graph of the release profile study for BMP 2 from HNTs for 7 days.
The release profile study of BMP 2 from HNTs was extended for a period of 7 
days. The experiment was repeated three times to reduce error and check for 
reproducibility of the results. The values are the means of the readings of BMP 2 from 
HNTs at the respective time points recorded from the three repetitions of the experiment. 
The error bars reflect the standard deviation at each data point calculated by standard 
deviation and the average of the triplicate samples (detailed process of calculation of the 
standard deviation described in Appendix B). [59]
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The release of BMP 2 from HNTs was extended and sustained for a period of 7 
days. The initial release was in picograms per ml range and after 24 hours was in 
nanograms per ml range. This range of released BMP 2 is comparable to the range BMP 
2 is effective in the body. The graph for BMP 2 release from the HNTs for a period of 7 
days shows a release profile which is characterized by an initial high burst of BMP 2 
release within initial 24 hours and later steady release for the period of 7 days. As 
described earlier, the release profile of BMP 2 for 24 hours was estimated by the use of 
custom made sandwich ELISA kits. The trend seen here is not of the cumulative release 
but that of individual data points. The concentration seen in the graph cannot be regarded 
as accurate estimate as the standards provided by the manufacturer showed resolution 
problems. The data should be viewed cautiously and regarded as a qualitative estimate of 
the protei released from the HNTs. The raw data tables and supplementary tables are 
provided in Appendix B.
The release profile of BMP 2 from the HNTs suggests that an extended and 
sustained release can be obtained from HNTs for a period of 7 days. The release is in pico 
and nanograms range which is the effective range for BMP 2 in natural tissue 
environment. Even though the concentrations cannot be regarded as accurate due to the 
resolution error in the kit, especially below the concentration of 50 pg/ml, the qualitative 
trend shows that the range in which the BMP 2 is released is comparable to the effective 
range in natural tissues. The results obtained for 7-day release are encouraging as the 
cellular differentiation process peaks at Day 7. Hence, a sustained release of BMP 2 for a 
period of 7 days from HNTs is beneficial for early onset of cellular differentiation which 
might lead to accelerated regeneration of the damaged bone tissue.
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The study of release of BMP 2 from HNTs could not be extended beyond 7-day
period as the growth factor degrades structurally at room temperature if kept beyond a
week. A comparison of release profiles of BMPs 4 and 6 from HNTs with BMP 2 would
have been ideal but could not be conducted as no ELISA kits were commercially
available to detect these molecules at picogram or nanogram range.
4.3.3 FE-SEM imagine and material testing with BET pore size 
and surface area analyses
4.3.3.1 FE-SEM imaging. Lyophilized calcium alginate hydrogel beads with and
without HNTs were FE-SEM imaged to visualize and compare the surface
morphologies of the beads. The study of the surface morphology is important as it
reveals changes that addition of HNTs brings about in calcium alginate hydrogels. A
modified surface might be more desirable with respect to the biological properties of
the hydrogel and might suggest other differences in the mechanical properties of the
HNT-calcium alginate hydrogels. Figure 4-47 compares the general morphologies of
lyophilized alginate-only and alginate+ HNTs hydrogel beads at 500 pm and 1 mm
magnification, respectively.
Figure 4-47. FE-SEM images showing A) Alginate-only bead and B) Alginate+ HNTs 
bead.
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Figure 4-47 (A) shows the general morphology of lyophilized alginate-only beads 
at 500 pm. The surface of the bead appears to have ridges and folds. Figure 4-47 (B) 
shows the general morphology of lyophilized alginate+ HNTs beads at 1 mm. The 
surface of the bead appears to have less ridges and folds than alginate-only bead (A). The 
surface also appears rougher than the alginate-only bead (A). The beads were imaged at 
different magnifications (500 pm for alginate-only bead and 1 mm for alginate+ HNT 
bead) as the alginate-only bead shrunk in size and surface features were not clearly 
visible at 1 mm magnification. Figure 4-48 (A-D) shows surface morphologies of 
alginate-only and alginate+ HNTs hydrogel beads at higher magnification.
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Figure 4-48. FE-SEM images showing the surface morphology of A) Alginate-only bead 
100 pm magnification B) Alginate+ HNTs bead 100 pm magnification C) Alginate-only 
bead 1 pm magnification D) Alginate+ HNTs bead with HNT protruding out of the 
surface at 1 pm magnification.
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Figures 4-48 (A and B) show the surfaces of alginate-only bead and alginate+ 
HNTs bead, respectively, at 100 pm magnification. The surfaces of both the beads look 
different with the image B showing a relatively rougher surface of alginate+ HNTs 
hydrogel bead. At 1 pm magnification the surface of alginate-only bead (C) looks rough 
and has finer creases and cracks. The image D shows the surface of alginate+ HNTs 
hydrogel bead with halloysite sticking out of the bead’s surface. The surface of the bead 
in image D also shows fold and minute surface elevations which might be due to 
halloysite bunches trapped in the hydrogel matrix.
A comparison of images in Figures 4-47 (A and B) and 4-48 (A-D) shows that the 
addition of HNTs modifies the surface of the hydrogels by making it rough and the bead 
more rigid. The rigidity o f the bead with HNTs was more as it did not shrink after 
lyophilization and retained it surface integrity without cracking.
4.3.3.2 BET pore size and surface area analysis o f hydrogels. BET pore size and
surface area analysis was done with helium adsorption-desorption method to analyze 
the material properties of the alginate-only and alginate+ HNTs hydrogels. This 
analysis would help to assess the differences in the material properties o f the hydrogels 
with the addition of HNTs. The curve used to plot the adsorption-desorption curve of 
helium for both the types of hydrogels is Langmuir curve. Figure 4-49 shows BET 
Langmuir isotherm showing the adsorption-desorption of helium for alginate-only 
hydrogel.
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Figure 4-49. BET Langmuir isotherm showing the adsorption-desorption of helium for 
alginate-only hydrogel.
Figure 4-49 shows Langmuir isotherm of adsorption-desorption of helium for 
alginate-only hydrogel. The red isotherm line is for adsorption of helium and blue line is 
for desorption. Both the lines (adsorption and desorption) have values that coincide for 
volume of gas at the respective values of relative pressure. The summary o f analysis 
showed that the cumulative surface area for the alginate-only hydrogel was 2.264 m2 /g, 
cumulative pore volume was 3.054 cc /g, and pore radius was 1.385 A. Figure 4-50
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shows BET Langmuir isotherm showing the adsorption-desorption of helium for 
alginate+ HNTs hydrogel.
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Figure 4-50. BET Langmuir isotherm showing the adsorption-desorption of helium for 
alginate+ HNTs hydrogel.
Figure 4-50 shows BET Langmuir isotherm of adsorption-desorption of helium 
for alginate+ HNTs hydrogel. The red isotherm line is for adsorption of helium, and the 
blue line is for desorption. Both the lines, unlike the isotherm curve for alginate-only 
hydrogel, show that the values for volumes of adsorbed and desorbed helium differ at the 
respective values of relative pressure. The results are summarized in Table 2.
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Table 2: BET results summary
Hydrogels Alginate Alginate + HNTs
Surface Area 8.485 m2/g 6.955 m2/g
Pore Volume 
(Cumulative) 3.054 cc /g 2.325 cc /g
Pore Radius 1.385 A l.o io  A
A comparison o f both the isotherms in Figures 4-49 and 4-50 shows that 
adsorption and desorption profiles of helium are different for both the types of hydrogels. 
The summary of analysis shows that the hydrogels also differ in their cumulative pore 
sizes and pore volumes significantly as can be seen in Table 2. Cumulative surface area 
of the hydrogels also differs slightly for both the types o f hydrogels. The alginate-only 
hydrogels have slightly larger cumulative surface area (2.264 m2 /g) than the alginate+ 
HNT hydrogels (2.099 m2 /g). The alginate-only hydrogels have cumulative pore volume 
of 3.054 cc /g which is larger than the cumulative pore volume of alginate+ HNTs 
hydrogels (cumulative pore volume = 2.325 cc /g). The pore size of alginate-only 
hydrogels is larger (pore radius = 1.385 A) than alginate+ HNT hydrogels (pore radius = 
1.01 A).
The summary of the BET pore size and surface area analysis suggests that 
addition of HNTs make the alginate hydrogels more rigid by reducing the pore size and 
volume. This alteration of material properties by the addition o f HNTs might make the 
Halloysite enhanced hydrogels better candidates than alginate-only hydrogels for implant 
materials.
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Looking at the results from the FE-SEM surface morphology analysis (Figure 4- 
47 and 4-48) and BET pore size and surface area analysis (Table 2, Figure 4-49 and 4-50) 
suggests that alginate+ HNTs have more rough surface and rigid structure making them 
structurally better suited as implant materials.
CHAPTER 5 
NANOSEEDS
5.1 Introduction
In the previous chapter, the concept of nanoenhanced bioactive hydrogels was 
discussed in detail. The results suggest that hydrogels can be enhanced with HNTs to 
improve their material and biological properties. Another potential application is the use 
o f nanoenhanced hydrogels as a chemoattractive delivery system designed to recruit the 
body’s own cells to populate and regenerate damaged bone tissue.
In Chapter 4, the base material for the hydrogels was calcium alginate. In the 
current chapter, calcium alginate is combined with similar materials such as calcium 
phosphate cement (CPC), chitosan lactate, and HNTs. The hydrogel composites 
comprised of calcium alginate, CPC, and chitosan were enhanced with HNTs loaded with 
BMP 2. The objective of the addition of the mentioned materials was to develop scaffold 
materials that can be used as chemoattractant beacons to attract progenitor cells to the site 
of injury.
CPCs, individually and in combination with chitosan lactate, has material 
properties which make them suitable materials to be used as bone cement. [25] Unlike 
PMMA, they do not produce toxic monomers or require high setting temperatures. [25, 
27] Apart from their desired material properties they also provoke a histogenic response 
from osteoblasts and mesenchymal stem cells. [25]
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The hypothesis of this project was that the combination of calcium alginate, CPC, 
and chitosan with BMP 2-loaded HNTs would enhance the material properties of the 
scaffolds and would act as chemoattractants for the osteoprogenitor cells.
5.2 Materials and Methods
All plasticware was obtained from Mid Scientific, St. Louis, MO. The chemicals 
met the ACS standards and purchased from Sigma Aldrich. Preosteoblasts were obtained 
from ATCC, Manassas, VA. The cell culture growth and maintenance medium were 
obtained from GEBCO, Life Technologies. The growth factor, BMP 2, was purchased 
from ProSpec Militany, Tel Aviv, Israel. The collagen type I, used for coating the seeding 
12 well plates, was obtained from GIBCO, Life Technologies (Grand Island, NY). The 
NucBlue Live Ready Probes, fluorescent vital stain was obtained from Thermo Fisher 
Scientific (Grand Island, NY). Histochemical stain kits: Von Kossa, Alcian Blue, and 
Picrosirius Red, were purchased from Polysciences Inc. (Warrington, PA).
5.2.1 Cell Migration Study
The cell migration study needed a matrix to hold the nanoseed constructs in place. 
The matrix also created a space where the cells could be seeded and held until they 
attached and began active migration. The matrix was made of collagen type I as it would 
mimic the body’s internal conditions and is an often used material in bioengineering. 
Collagen type I is the most abundant component o f connective tissues in the body, in the 
scar tissue and also makes up the organic component of bones. [45]
5.2.1.1 Coatine cell culture well plates and seedine. The coating procedure is 
described in Section 3.2.4. After coating the wells, the plates were kept in 37 °C 
incubator for the collagen gels to form. The gels were lightly washed with HBSS buffer
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to remove the traces of chemicals. Hydrogel nanoseed constructs were prepared as per 
the procedure described in Section 3.2.1 and enhanced with HNTs vacuum loaded with 
BMP 2 as per the process described in Section 3.2.2.1. The nanoseeds were placed at a 
comer of the coated well and cell suspension was injected in the collagen matrix at the 
opposite comer. The growth medium was added after 30 minutes to avoid eluting out 
the seeded cells. The cells in the suspension were treated with NucBlue fluorescent 
stain as per the procedure described in Section 3.2.5.2.
5.2.1.2 Fixing the eel matrices and histochemical stainine. The gel matrices with the
nanoseeds and the cells were fixed on Days 0, 3, and 7. The cells were imaged on the
respective days to visualize their migration in response to the eluted BMP 2 from the
nanoseeds. The differentiation response of the cells was visualized by staining with
histochemical stains (Alcian Blue and Von Kossa). The histochemical staining
procedures for Alcian Blue and Von Kossa are described in details in Sections 3.2.5.3,
3.2.5.4, and 3.2.5.5 Picrosirius Red staining was not suitable for this study as the cells
were seeded on collagen gel matrix and Picrosirius Red stains for collagen.
5.2.2 Release profile study of BMP 2 from HNTs and various
hvdrogel composites
The release profile for BMP 2 was studied in the previous project with the 
alginate hydrogels. This release profile study focused only on the elution of BMP 2 from 
the HNTs. For the nanoseed hydrogels to be chemoattractant, the BMP 2 needs to be 
eluted out of the hydrogels. In this project, the release profile of BMP 2, both from HNTs 
and hydrogels enhanced with HNTs loaded with BMP 2, was studied. The detailed 
procedure for release profile study is given in Section 3.2.6.
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5.2.3 FE-SEM imagine and comparison of surface morphologies of 
different hvdroeel composites
The hydrogel composites consisting of calcium alginate as the base material were 
enhanced with materials like CPC, chitosan lactate, and HNTs. This was done to improve 
the mechanical properties and also the osteogenic response of the bone progenitor cells. 
[25]
To compare and contrast the different surface morphologies of the hydrogel 
composites, the hydrogel constructs were lyophilized and imaged under FE-SEM. The 
detailed process is described in Section 3.2.3.
5.2.4 Preosteoblast pilot study using the composite hydrogels
The cells after migration should be able to proliferate and differentiate on the 
hydrogel composites to achieve the purpose of tissue regeneration. A pilot study was 
conducted to test if the hydrogels provide the cells a favorable surface for differentiation.
The cells were seeded onto the hydrogel composite films directly. The study was 
conducted for a period of 3, 7, and 14 days. The hydrogel composite films were fixed 
with the cells on them on Day 3, 7, and 14. As the films were too thick for the light to 
pass through, microscopic imaging could not be performed. Instead, the films were 
subjected to an indirect stain elution study to quantify the differentiation markers.
The films were stained as per the protocols for Alcian Blue and Picrosirius Red 
stains. The stained films were then washed with 7% v/v acetic acid and the stains were 
eluted with the samples stored at 4°C. The UV/VIS mode of NANODROP 2000 
spectrophotometer was used to determine the absorbance of the samples and the values 
were plotted to estimate the amount of mucopolysaccharides, in case of Alcian Blue 
stain, and collagen, in case of Picrosirius Red stain.
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5.3 Results and Discussion
This section discusses the results from experiments detailed in Section 5.2 of the 
current chapter.
5.3.1 Histochemical Analysis
The histochemical analysis of the gel matrices seeded with preosteoblasts and 
hydrogel composite constructs was done to assess if  the cells migrated and differentiated 
in response to the secreted BMP 2. If the cells were found to have moved from the 
location of injection or seeding (cell reservoir), it would suggest the chemoattractant 
potential of the HNT-BMP 2 enhanced hydrogel composites.
5.3.1.1 Alcian Blue staininz. Alcian Blue staining, in this project, was done to 
analyze the response of the cells to the secreted BMP 2 during or after their migration 
towards the hydrogels or nanoseeds. Alcian Blue stains the acidic mucopolysaccharides 
of the ECM formed after the cellular differentiation. Figures 5-1 to 5-3 show the Alcian 
Blue staining for Days 1, 3, and 7. Figure 5-1 (A-F) shows the Alcian Blue staining for 
Day 1.
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Figure 5-1. Day 1 Alcian Blue Staining of the preosteoblast cells on collagen matrices 
with hydrogel nanoseed constructs. A) Well 1 with alginate-only hydrogels B) Well 2 
with alginate+ HNT+ BMP 2 C) Well 3 alginate+ CPC + HNT D) Well 4 alginate + 
CPC+ HNT+ BMP 2 E) Well 5 alginate+ CPC+ Chitosan lactate + HNT F) Well 6 
alginate+ CPC+ Chitosan lactate + HNT+ BMP 2.
Figure 5-1 (A-F) shows Day 1 Alcian Blue staining for the cells in response to 
different hydrogel composite constructs with or without BMP 2. These images only show 
the cell reservoir that is the site of initial cell seeding. The cells have attached themselves 
and are proliferating in the collagen I matrix after seeding. Figure 5-1 (A) shows the 
control with alginate-only hydrogel construct and cells seeded in cell reservoir at the 
opposite pole. Figures 5-1 (B-F) are all experimental groups showing alginate hydrogel 
composite constructs. In all the groups (control and experimental) the cells are attached to 
the collagen matrix and are proliferating. This state suggests that the matrices have
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retained their cellular properties and the cells are growing normally in the matrix. Figure 
5-2 shows Day 3 Alcian Blue staining.
104
Figure 5-2. Day 3 Alcian Blue staining of the preosteoblast cells on collagen matrices 
with hydrogel nanoseed constructs. A) Well 1 with alginate-only hydrogels, site of initial 
seeding B) Well 1 with alginate-only hydrogels, center C) Well 2 with alginate+ HNT+ 
BMP 2, site of initial seeding D) Well 2 with alginate+ HNT+ BMP 2, center E) Well 3 
alginate+ CPC+ HNT, site of initial seeding F) Well 3 alginate+ CPC+ HNT, center G) 
Well 4 alginate + CPC+ HNT+ BMP 2, site of initial seeding H) Well 4 alginate + CPC+ 
HNT+ BMP 2, center I) Well 5 alginate+ CPC+ Chitosan lactate + HNT, site of initial 
seeding J) Well 5 alginate+ CPC+ Chitosan lactate + HNT, center K) Well 6 alginate+ 
CPC+ Chitosan lactate + HNT+ BMP 2, site of initial seeding L) Well 6 alginate+ CPC+ 
Chitosan lactate + HNT+ BMP 2, center.
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Figure 5-2 (A-L) shows Day 3 staining of the cells in response to the hydrogel 
composites or nanoseeds. Figure 5-1 (A and B) shows cells at the site of injection and 
center, respectively, for alginate-only hydrogels (control). The images show that the cells 
have proliferated and have started producing ECM at the site of injection or seeding but 
there is no migration towards the hydrogel bead. This suggests that the alginate itself 
does not have chemoattractant properties. Figure 5-2 (C and D) shows cells at the site of 
injection and center, respectively, for alginate+ HNTs+ BMP 2 (experimental group).
The images show the cells attached and producing ECM. Some of the cells have migrated 
towards the bead in response to BMP 2 as seen in the image D.
Figure 5-2 (E and F) shows cells at the site of injection and center, respectively, 
for alginate+ CPC+ HNTs. The images show the cells attached and producing ECM. 
There is no migration towards the bead suggesting the composite (alginate+ CPC+
HNTs) is not chemoattractant in itself. Figure 5-2 (G and H) shows cells at the site of 
injection and center, respectively, for alginate+ CPC+ HNTs+ BMP 2. The images show 
the cells have attached and are producing ECM. Some of the cells have also migrated 
towards the hydrogel composite bead in response to BMP 2.
Figure 5-2 (I and J) shows cells at the site of injection and center, respectively, for 
alginate+ CPC+ Chitosan lactate+ HNTs. The images show that the cells have attached 
and are producing ECM but there is no migration towards the hydrogel composite bead 
suggesting that the composite bead is not chemoattractant. Figure 5-2 (K and L) shows 
cells at the site of injection and center, respectively, for alginate+ CPC+ Chitosan 
lactate+ HNTs+ BMP 2. The images show that the cells have attached and are producing 
ECM. The image showing the center (L) of die gel matrix shows that some of the cells
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have migrated towards the bead in response to the BMP 2. Figure 5-3 (A-L) shows 
Alcian Blue staining for Day 3.
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Figure 5-3. Day 7 Alcian Blue staining of the preosteoblast cells on collagen matrices 
with hydrogel nanoseed constructs. A) Well 1 with alginate-only hydrogels, site of initial 
seeding B) Well 1 with alginate-only hydrogels, center C) Well 2 with alginate+ HNT+ 
BMP 2, site of initial seeding D) Well 2 with alginate+ HNT+ BMP 2, center and near 
bead (insert) E) Well 3 alginate+ CPC + HNT, site of initial seeding F) Well 3 alginate+ 
CPC + HNT, center G) Well 4 alginate+ CPC+ HNT+ BMP 2, site of initial seeding H) 
Well 4 alginate + CPC+ HNT+ BMP 2, center and near bead (insert) I) Well 5 alginate+ 
CPC+ Chitosan lactate + HNT, site of initial seeding J) Well 5 alginate+ CPC+ Chitosan 
lactate + HNT, center K) Well 6 alginate+ CPC+ Chitosan lactate+ HNT+ BMP 2, site of 
initial seeding L) Well 6 alginate+ CPC+ Chitosan lactate+ HNT+ BMP 2, center and 
near bead (insert).
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Figure 5-3 (A-L) shows Day 7 Alcian Blue staining for the cells in response to 
different hydrogel composite constructs with or without BMP 2. Figure 5-3 (A and B) 
shows cells that have produced deep blue stained ECM at the site of injection (A) and no 
migration towards the control bead (B). Figure 5-3 (C and D) shows deeply stained ECM 
producing cells at the site of injection (C), migrating cells at the center and also to the end 
where the alginate+ HNTs+ BMP 2 hydrogel bead is located (D, and the insert). The 
migrating cells are also more as compared to the Day 3 images (Figure 5-2, D).
Figure 5-3 (E and F) shows cells producing deep blue stained ECM (E) and no 
migration towards the alginate+ CPC+ HNTs bead (F). Figure 5-3 (G and H) shows the 
cells that are producing deep blue stained ECM (G) and there is migration towards the 
alginate+ CPC+ HNTs+ BMP 2 bead shown by the image H and the insert. The cells at 
the center o f the collagen gel matrix show that they have started differentiating and some 
of the cells have migrated near the bead.
Figure 5-3 (I and J) shows the cells producing deep blue stained ECM matrix and 
no migration towards alginate+ CPC+ Chitosan lactate+ HNTs bead. Figure 5-3 (K and 
L) shows a dense ECM matrix produced by the cells and no individual cells can be seen 
in the matrix. The site of injection shows a continuous ECM produced by the 
differentiating cells (K) and the cells that have migrated towards the bead have produced 
ECM as well as can be seen in image L and insert.
As can be seen in Figure 5-3 (K and L), the migration is complete and the cells 
produce ECM in response to the BMP 2. This is the construct that has the most cells 
migrating and producing ECM uniformly as compared to other constructs. The images 
with constructs or nanoseeds with BMP 2 in the HNTs show that cells are attracted
109
towards them and differentiate. The alginate composites without the growth factor, BMP 
2, are not chemoattractants.
5.3.1.2 Von Kossa staining. Von Kossa stains the phosphate group, in calcium
phosphate, brown-black. Calcium phosphate is also known as hydroxyapatite and is the 
inorganic component of bone. The Von Kossa staining, in this project, would help in 
visualizing the calcium phosphate secreted by the cells in response to the BMP 2 
released from the hydrogel constructs. Figures 5-4, 5-5, and 5-6 show the Von Kossa 
staining for alginate hydrogel composites or nanoseeds. Figure 5-4 (A-F) shows the 
Von Kossa staining of the cells for different alginate hydrogel composites or nanoseeds 
on Day 1.
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Figure 5-4. Day 1 Von Kossa Staining of preosteoblast cells on collagen matrices with 
hydrogel nanoseed constructs. A) Well 1 with alginate-only hydrogels B) Well 2 with 
alginate+ HNT+ BMP 2 C) Well 3 alginate+ CPC + HNT D) Well 4 alginate + CPC+ 
HNT+ BMP 2 E) Well 5 alginate+ CPC+ Chitosan lactate + HNT F) Well 6 alginate+ 
CPC+ Chitosan lactate + HNT+ BMP 2.
Image A shows cells that have attached and are proliferating on the collagen gel 
matrix in the well containing the alginate-only hydrogel control bead. The experimental 
groups are shown in images B-F. The cells in these images are also well attached and are 
proliferating, suggesting that the collagen gel matrices provide a conducive environment 
for cellular growth and that no inhibitory effect is seen on Day 1.
Figures 5-5 (A-L) show the Von Kossa staining for Day 3 for the alginate 
hydrogel composite constructs.
Ill
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Figure 5-5. Day 3 Von Kossa staining of the preosteoblast cells on collagen matrices 
with hydrogel nanoseed constructs. A) Well 1 with alginate-only hydrogels, site of initial 
seeding B) Well 1 with alginate-only hydrogels, center C) Well 2 with alginate+ HNT+ 
BMP 2, site of initial seeding D) Well 2 with alginate+ HNT+ BMP 2, center E) Well 3 
alginate+ CPC+ HNT, site of initial seeding F) Well 3 alginate+ CPC + HNT, center G) 
Well 4 alginate + CPC+ HNT+ BMP 2, site of initial seeding H) Well 4 alginate + CPC+ 
HNT+ BMP 2, center I) Well 5 alginate+ CPC+ Chitosan lactate + HNT, site of initial 
seeding J) Well 5 alginate+ CPC+ Chitosan lactate + HNT, center K) Well 6 alginate* 
CPC+ Chitosan lactate + HNT+ BMP 2, site o f initial seeding L) Well 6 alginate+ CPC+ 
Chitosan lactate + HNT+ BMP 2, center.
Figure 5-5 (A and B) show the cells in the control group. The cells have started to 
differentiate and are producing calcium phosphate deposits at the site of injection seen as 
small brown-black spots in image A. There is no migration towards the bead, as seen in 
image B. Figure 5-5 (C and D) show the cells in well with alginate* HNTs+ BMP 2. 
Image C shows larger brown-black spots at the site of injection suggesting differentiating 
cells. Image D shows the center o f the matrix with differentiating cells and brown 
patches.
Figures 5-5 (E and F) show the differentiating cells in well with alginate+ CPC* 
HNTs producing calcium phosphate (brown spots) at the site of injection (E) and no 
migration of the cells (F). Figure 5-5 (G and H) shows the differentiating cells in well 
with alginate* CPC* HNTs* BMP 2. Image G shows the differentiating cells producing
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calcium phosphate as brown patches at the site of injection. Image H shows the migrating 
cells which are differentiating at the center of the collagen gel matrix producing calcium 
phosphate deposits as brown patches.
Figures 5-5 (I and J) show the differentiating cells in the well with alginate+
CPC+ Chitosan lactate+ HNTs. Image I shows differentiating cells producing calcium 
phosphate deposits as brown patches and no migration towards the bead as seen in image 
J. Figures 5-5 (K and L) show the differentiating cells in the well with alginate+ CPC+ 
Chitosan lactate+ HNTs+ BMP 2. Image K shows the differentiating cells producing 
calcium phosphate seen as brown spots and image L shows the migrating and 
differentiating cells producing the calcium phosphate deposits. Overall, Figure 5-5 
shows that most calcium phosphate production takes place in the well with the 
differentiating cells in the well with alginate+ CPC+ Chitosan lactate+ HNTs+ BMP 2 (K 
andL).
Figure 5-6 (A-L) shows the Von Kossa staining for Day 7 for alginate hydrogel 
composites or nanoseeds.
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Figure 5-6. Day 7 Von Kossa staining of the preosteoblast cells on collagen matrices 
with hydrogel nanoseed constructs. A) Well 1 with alginate-only hydrogels, site of initial 
seeding B) Well 1 with alginate-only hydrogels, center C) Well 2 with alginate+ HNT+ 
BMP 2, site of initial seeding D) Well 2 with alginate+ HNT+ BMP 2, center E) Well 3 
alginate+ CPC + HNT, site of initial seeding F) Well 3 alginate+ CPC + HNT, center G) 
Well 4 alginate + CPC+ HNT+ BMP 2, site of initial seeding H) Well 4 alginate + CPC+ 
HNT+ BMP 2, center and near bead (insert) I) Well 5 alginate+ CPC+ Chitosan lactate + 
HNT, site of initial seeding J) Well 5 alginate+ CPC+ Chitosan lactate + HNT, center K) 
Well 6 alginate+ CPC+ Chitosan lactate + HNT+ BMP 2, site of initial seeding L) Well 6 
alginate+ CPC+ Chitosan lactate + HNT+ BMP 2, center and near bead (insert).
Figure 5-6 (A and B) show the differentiating cells in the control well. The cells 
have produced calcium phosphate deposits at the site of injection (A) and cells have not 
migrated towards the control bead (B). Figure 5-6 (C and D) shows the differentiating 
cells in the well with alginate+ HNTs+ BMP 2. The cells have produced calcium 
phosphate seen as brown spots at the site of injection (C) and at the center of the collagen 
gel matrix by the cells that have migrated towards the bead (D).
Figure 5-6 (E and F) shows the differentiating cells in the well with alginate+ 
CPC+ HNTs. The cells at the site of injection have produced calcium phosphate deposits 
that are seen as dark brown or black patches (E) and no migration seen towards the bead 
(F). Figure (G and H) shows the differentiating cells in the well with alginate+ CPC+
HNTs+ BMP 2. The cells at the site of injection have produced calcium phosphate
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deposits (G) the cells have migrated and differentiated towards the bead in response to 
the BMP 2 (H and the insert).
Figure 5-6 (I and J) shows the differentiating cells in the well with alginate+
CPC+ Chitosan lactate+ HNTs. The cells produce dark brown stained calcium phosphate 
deposits at the site of injection (I) and the cells have not migrated towards the bead as can 
be seen in image J. Figure 5-6 (K and L) shows the differentiating cells in the well with 
alginate+ CPC+ Chitosan lactate+ HNTs+ BMP 2. The cells at the site of injection (K) 
and the migrating cells (L and insert) show calcium phosphate production seen as dark 
brown patches.
As seen in all of the figures above, cells differentiate after Day 3 in all the wells at 
the site of injection but migrate and differentiate towards the hydrogel beads or 
nanoseeds with BMP 2 in the HNTs. This suggests that the alginate hydrogel composites 
without BMP 2 are not chemoattractants.
The observations from both the histochemical staining experiments (Alcian Blue 
and Von Kossa) suggest that alginate hydrogel composites enhanced with HNTs with 
BMP 2 can act as chemoattractants and induce cellular migration and differentiation in 
vitro. The observations from the histochemical staining experiments suggest that the 
nanoseeds have potential to be used as implant material for bone regeneration. The 
following subsections will further illustrate if the alginate hydrogel constructs 
(nanoseeds) have the potential to function as implant materials.
5.3.1.3 Preosteoblast pilot study on the composite hvdrozels. A pilot study of
seeding preosteoblasts directly on composite hydrogel films with HNTs but without any 
growth factors was done to see if the alginate hydrogels enhanced with CPC, chitosan
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lactate, and HNTs have any effect on the cellular differentiation. The study was done 
for a 14 day period and the samples were taken for histochemical staining on Days 3,7, 
and 14. The hydrogel composite films with the preosteoblasts were stained with 
histochemical stains Alcian Blue and Picrosirius Red and then these films were 
destained as described in the methods section. Figure 5-7 shows the Alcian Blue 
staining and quantitative analysis by Nanodrop 2000 spectrophotometry.
■  CPC+Alginate
■  CPC+Alginate+Chitosan
■  CPC+Alginate+Chitosan+HNTs
Figure 5-7. Graph showing the absorbance (at 450-495 nm) of the eluted Alcian Blue 
stain against the number of days and different hydrogel composition. (n=6), p<0.05. Error 
bars show standard deviation.
The graph in Figure 5-7 shows the absorbance of the eluted Alcian Blue 
stain against the number of days for different hydrogel composites. Alcian Blue 
staining results shows that the CPC + alginate films had synthesized a greater
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amount of proteoglycan Day 3 (Mean: 1.93158) but there was a drop by Day 14 
(Mean: 1.22901). The CPC + alginate films also had comparatively more ECM 
than the rest of the films as shown in Figure 8 on Day 3. The CPC+ alginate+
Chitosan films maintained ECM levels relatively equal on Days 3 (Mean: 1.7848),
7 (Mean: 1.89605) and 14 (Mean: 1.6552). The CPC+ alginate+ Chitosan+ HNTs 
films had the least ECM polysaccharides on Day 3 (Mean: 1.586) when compared 
against the other scaffolds. The levels of ECM polysaccharides decreased on Day 7 
(Mean: 1.25685) but remained relatively similar on Day 14 (Mean: 1.3081).
Picrosirius Red staining was done for estimating the amount of collagen produced 
by the cells on the hydrogel composite films. Figure 5-8 shows the Alcian Blue staining 
and quantitative analysis by Nanodrop 2000 spectrophotometry.
■  CPC+Alginate
■  CPC+Alginate+Chitosan
■  CPC+Alginate+Chitosan+HNTs
Figure 5-8. Graph showing the absorbance (at 620-750 nm) of the eluted Picrosirius Red 
stain against the number of days. (n=6), p<0.05. Error bars show standard deviation.
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Figure 5-8 shows the graph of absorbance of the eluted Picrosirius Red stain 
against the number of days for different hydrogel composites. Picrosirius Red 
staining data showed that the CPC+ alginate films had accumulated the less amount 
of collagen on Day 3 (Mean: 1.35) but increased by Day 7 (Mean: 2.46) with a 
decrease noted on Day 14 (Mean: 1.74). The CPC+ alginate films also had 
produced a lesser amount of collagen when compared with the other two coatings 
(Figure 9). In contrast, CPC+ alginate+ chitosan films produced an initial higher 
amount of collagen (Mean: 2.1781), which increased on Day 7 (Mean: 2.97) and 
remained somewhat similar through Day 14 (Mean: 2.9198). CPC+ alginate+ 
chitosan+ HNT films produced the most collagen by Day 3 (Mean: 2.74) when 
compared against the other scaffolds. The levels of collagen increased slightly on 
Day 7 (Mean: 2.9196) and decreased in amount by Day 14 (Mean: 2.30). The 
cumulative supports the observation that cells on all substrates produced a base 
organic extracellular matrix.
A two ANOVA with replacement was used to check for the significance of the 
results at a=0.05 for both the experiments (Alcian Blue and Picrosirius Red assays). The 
statistical analysis was conducted by using MS Excel 2013 Toolpak® The statistical 
analyses showed that there was significance across the days and across the groups with 
CPC+ alginate and CPC+ alginate+ Chitosan + HNTs for Alcian Blue staining as 
suggested by the higher F-stat values against F-critical values. There was also a 
significant interaction within the groups across days suggesting that the trend seen in the 
graph is significant. For Picrosirius Red staining there was significance observed for the 
group CPC+ alginate+ Chitosan for all the three days as suggested by the higher F-stat
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values against F-critical values. There was also a significant interaction within the groups 
across days suggesting that the trend seen in the graph is significant.
The cumulative observation of both the stain elution studies suggests that all the 
hydrogel composites support the ECM and collagen production on all days. A 
relationship was observed between the two graphs of stain elution studies for ECM 
mucopolysaccharides and collagen production throughout the 14 day period. While the 
cells on CPC/alginate produced more ECM mucopolysaccharides on Day 3 the cells on 
other groups namely, CPC/alginate+ Chitosan and CPC/alginate+ Chitosan+ HNTs, 
synthesized more collagen. The production of ECM mucopolysaccharides and collagen, 
both are important for the differentiating cells as this is the organic template for the 
formation of new bone.
Looking at both the graphs (Figures 5-7 and 5-8), CPC/alginate+ Chitosan was 
the composition that produced both ECM mucopolysaccharides and collagen in relatively 
stable amounts throughout all the days. The next composition to follow is CPC/alginate+ 
Chitosan+ HNTs which produced comparable amounts of ECM mucopolysaccharides 
and collagen on Days 7 and 14.
5.3.2 Release Study of BMP 2 from HNTs and Various Hydrogel Composites
In the previous project, the release profile of BMP 2 from HNTs was studied. In 
the current project, the objective of studying the release profile of BMP 2 was to 
determine if it is released out of the hydrogel matrix and the concentration of the released 
BMP 2. This would suggest that the BMP 2 is indeed, released out of the hydrogels and 
not just out of the HNTs and would suggest the hydrogel constructs have chemoattractant 
potential.
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5.3.2.1 Release profile o f BMP 2 from HNTs. The release profile study of BMP 2 
from HNTs was repeated to check the reproducibility of the release profile experiment 
observations from the previous nanoenhanced bioactive hydrogels project. The 
experiments were repeated for a period of 24 hours and 7 days. Figure 5-9 shows the 
calibration curve for BMP 2 standards.
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Figure 5-9. Calibration curve for BMP 2 standards with absorbance (OD) and the 
corresponding concentrations.
Figure 5-9 shows the calibration curve for BMP 2 standards that were used to 
calculate the concentration of BMP 2 released from the HNTs and hydrogels. Figure 5-10 
shows the conversion for the absorbance values and the corresponding concentrations.
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Figure 5-10. Graph for conversion for the absorbance OD values to corresponding 
concentrations.
Figure 5-10 shows the graph with the conversion for the absorbance to 
concentration. Figure 5-11 shows the BMP 2 release from HNTs for 24 hours.
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Figure 5-11. Graph showing release of BMP 2 from the HNTs for 24 hours.
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The graph in Figure 5-11 shows that the results of the release profile of BMP 2 
from the previous study are reproducible as they are comparable. The release of BMP 2 
from HNTs is sustained for a period of 24 hours. The objective of this study was to 
confirm that the growth factor is released into the hydrogel matrix and the graph shows 
the release for a period of 24 hours. The error bars represent the standard deviation 
calculated by the standard deviation of the data point and the average of the triplicate 
samples (detailed process of calculation of the standard deviation described in Appendix 
B). [59]
As described earlier, the release profile of BMP 2 for 24 hours was estimated by 
the use of custom made sandwich ELISA kits. The trend seen here is not of the 
cumulative release but that of individual data points. The concentration seen in the graph 
cannot be regarded as accurate estimate as the standards provided by the manufacturer 
showed resolution problems. The data should be viewed cautiously and regarded as a 
qualitative estimate of the protein released from the HNTs. The raw data tables and 
supplementary tables are provided in Appendix B.
The study was extended to a period of 7 days to check if the growth factor is 
released for extended periods form the HNTs. Figure 5-12 shows the graph of release 
profile o f BMP 2 from HNTs for 7 days.
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Figure 5-12. Graph showing the release profile of BMP 2 from HNTs for 7 days.
Figure 5-12 shows the graph for BMP 2 release profile from HNTs for a 7 day 
period. This graph validates that the results obtained in previous study are reproducible 
and also confirms that the HNTs release the growth factor in the hydrogel matrix for an 
extended period of 7 days. The calibration curves used for the calculation of the values 
are die same given in Figure 5-9 and 5-10. The release of the growth factor is in 
nanograms per ml range. The error bars represent the standard deviation calculated by the 
standard deviation of the data point and the average of the triplicate samples (detailed 
process o f calculation of the standard error described in Appendix B). [59]
The release profile of BMP 2 from the HNTs suggests that an extended and 
sustained release can be obtained from HNTs for a period of 7 days. The release is in pico 
and nanograms range which is the effective range for BMP 2 in natural tissue 
environment. Even though the concentrations cannot be regarded as accurate due to the
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resolution error in the kit, especially below the concentration of 50 pg/ml, the qualitative 
trend shows that the range in which the BMP 2 is released is comparable to the effective 
range in natural tissues. The results obtained for 7-day release are encouraging as the 
cellular differentiation process peaks at Day 7. Hence, a sustained release of BMP 2 for a 
period of 7 days from HNTs is beneficial for early onset of cellular differentiation which 
might lead to accelerated regeneration of the damaged bone tissue.
5.3.2.2 Release profile o f BMP 2 from HNT enhanced hvdroeels. The release profile
study of BMP 2 from hydrogels enhanced with HNTs was carried out to investigate if 
the BMP 2 was released from the hydrogels into the surrounding medium. The study 
was conducted for a period of 36 hours.
Figure 5-13 shows the release profile graph of BMP 2 from hydrogels enhanced 
with growth factor loaded HNTs.
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Figure 5-13. Graph of release profile o f BMP 2 from hydrogels enhanced with HNTs.
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Figure 5-13 shows the release profile of BMP 2 from the HNTs in hydrogel 
matrix. The calibration curves used are the same used in Figure 5-9 and 5-10. The graph 
shows a qualitative trend and the concentrations are not accurate as mentioned earlier due 
to the resolution problem and noise in the standards of the kit.
The trend shows an extended and sustained release can be observed for a period 
of 36 hours in the above graph. This result supports the observation that the cells 
migrated towards the nanoseeds (Nanoenhanced hydrogels with BMP 2 loaded HNTs) 
placed at one end of the collagen gel matrix in Section 5.3.1. The growth factor is 
released out of the gel matrix serving as the chemoattractant signal.
It would have been ideal to have a release profile for 7 days. The experiment 
could be performed only for a period of 36 hours or three days as the hydrogels broke in 
the HBSS solution due to continuous rocking of the platform. The error bars represent the 
standard deviation calculated by the standard deviation of the data point and the average 
of the triplicate samples (detailed process of calculation of the standard deviation is 
described in Appendix B). [59]
5.3.3 FE-SEM Imagine and Comparison of the Hydrogel 
Composites Surface Morphologies
FE-SEM imaging was done to understand the differences between the surfaces of 
die alginate hydrogels when enhanced with CPC, Chitosan lactate, and HNTs. It is 
important to understand how the surfaces are modified by the addition of the composite 
materials as this will shed light on the material interactions and some of the material 
properties that are altered. Figure 5-14 shows a general comparison of the surfaces and 
overall morphology of the hydrogel beads with addition of the composite materials at 
lower and higher magnification.
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Figure 5-14. A comparison of different hydrogel constructs surface morphologies at 
higher magnification.
Figure 5-14 shows a general overview of the surface morphologies of the alginate 
hydrogel composite beads. The lower magnification images show the overall 
morphologies of the hydrogel beads. The alginate-only bead has smooth surface and 
looks shriveled compared to the rest of the hydrogel composites. The hydrogel beads with 
HNTs, CPC, and chitosan lactate have retained their size and shape even after 
lyophilization and have rough surfaces. The bead with alginate+ CPC+ chitosan lactate 
has the most rigid and well retained structure after lyophilization. The ridges and surface 
features are uniform and well defined in this composition of the hydrogel composite.
The higher magnification images in Figure 5-14 show the corresponding surfaces 
in details for the respective alginate hydrogel composite compositions, alginate-only 
hydrogel shows a relatively smooth surface devoid of any surface features. The alginate+ 
HNTs and alginate+ CPC hydrogels have relatively rough surface. The most well defined
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surface features can be seen in the higher magnification image of alginate+ CPC+ 
chitosan lactate bead with well-defined ridges and grooves. These images provide a 
general understanding of how the surfaces get modified by the addition of composite 
materials. Figure 5-15 (A-D) shows the surface topography of the alginate composites in 
greater details at higher magnifications.
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Figure 5-15. FE-SEM images of A) alginate-only B) alginate+ HNTs C) alginate+ CPC 
and D) alginate+ CPC+ Chitosan showing the surface morphology at 100 pm 
magnification.
Figure 5-15 (A and B) show the FE-SEM images of alginate-only and alginate+ 
HNTs hydrogel beads at 100 pm scale. The surface of alginate-only hydrogel (control) 
looks smooth and there are no ridges or grooves on the surface. There are only slight 
elevations with few pores visible in the image. The surface of the hydrogel with HNTs 
shows a relatively rough surface with small and sharp mound like elevations protruding 
out of the surface. No pores or ridges and grooves are visible in the image.
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Figure 5-15 (C and D) show the FE-SEM images of alginate hydrogels enhanced 
with CPC (C) and CPC+ Chitosan lactate (D). The surface alginate+ CPC hydrogel 
shows distinct ridges and grooves and some pores sunken in the surface. The elevations 
protruding out of the surface look uniform giving a well-defined appearance to the 
surface of the bead (C). The surface of the alginate+ CPC+ chitosan lactate bead shows 
longer elevations as compared with alginate+ CPC hydrogel bead. Ridges and grooves 
are not visible at this magnification but pores can be seen on the mound shaped 
elevations (D). The surface also appears to be rougher when compared to surfaces of 
alginate-only and alginate+ HNTs hydrogel beads (A and B). Figure 5-16 shows the 
surface topography of the alginate hydrogel composites at higher magnification (10 pm)
Figure 5-16. FE-SEM images of A) alginate-only B) alginate+ HNTs C) alginate+ CPC 
and D) alginate+ CPC+ Chitosan showing the surface morphology at 10 pm 
magnification.
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Figure 5-16 (A-D) shows FE-SEM images of the alginate hydrogel composite 
surfaces at higher magnification (10 pm scale). The surface of the alginate-only hydrogel 
(A) shows an area of rough surface surrounded by smooth surface. This rough surface 
looks sunken into the bead and might have resulted out of scratch during handling of the 
bead. alginate+ HNTs hydrogel (B) shows relatively smaller elevations and HNTs 
sticking out of the surface. The alginate+ CPC hydrogel (C) surface looks crumpled and 
has sharp ridge like elevations. The alginate+ CPC+ Chitosan lactate (D) surface shows 
similar elevations as seen in image C but the elevations are larger.
Comparing all the images from Figures 5-14, 5-15, and 5-16, the observations 
suggest that addition of composite materials like HNTs, CPC, and chitosan lactate 
modifies the surface of alginate hydrogels and makes it rougher with surface features like 
elevations, ridges, and grooves. The modification of surface might be beneficial for 
cellular attachment as cells will find a favorable surface to anchor themselves on to the 
hydrogels. The enhancement of alginate hydrogels with the composite materials will 
make the hydrogels more suitable as implant materials.
CHAPTER 6
HYDROGEL COATINGS FOR TITANIUM IMPLANTS
6.1 Introduction
Severe bone injuries have been secured by orthopedic implants for over fifty 
years. [48] Stainless steel was replaced by titanium became of its excellent 
biocompatibility. [48] Titanium and its alloys do not corrode as seen in stainless steel and 
other metal alloys. [48] It is relatively inert and has suitable material properties that make 
useful for stabilizing broken bone fragments. [48] Despite of its virtues, titanium faces 
certain drawbacks such as it failure to osteointegrate with surrounding bone tissue and it 
is prone to post-surgical infections. [20,26, 37]
Post-surgical infections are one of main causes of the titanium implant failure.
[20,26, 37] In worst case, the implant needs to be completely removed from the body, 
the surrounding tissue debrided and cleaned, and a new implant be inserted at the site of 
injury. [35] This procedure can lead to complications due to patient’s physiological state, 
health status, age, and clinical condition.
In the previous chapters (Chapters 4 and 5), the applications of calcium alginate 
and composite hydrogels have been discussed in detail. In the current chapter, the 
application of bioactive hydrogels enhanced with CPC, chitosan lactate and HNTs loaded 
with anti-infective drug, gentamicin sulfate, is discussed. Gentamicin sulfate (henceforth
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referred to as GS) is widely used in the field of orthopedic medicine to treat infections 
from gram-negative strains of bacterium. [38]
The primary hypothesis of this project was to develop anti-infective hydrogel 
coatings for titanium implants that will inhibit the growth of gram negative bacterium, E. 
coli, in this study. The secondary hypothesis was to investigate if anodization of the 
surface retains or enhances the osteogenic properties of titanium by laying hydroxyapatite 
foundation to make it favorable to the osteogenic cells and enhancing its osteointegration. 
The graphical representation in Figure 6-1 below shows the objectives and the construct 
with anodized titanium and anti-infective hydrogel.
Figure 6-1. Graphical representation of the anti-microbial hydrogel (H) coating applied 
to anodized titanium (AT). From left to right, bacteria (B) encounter the anti-microbial 
hydrogel and released gentamicin (G) altering their metabolism leading to cell death. T = 
titanium.
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6.2 Materials and Methods
Plasticware was obtained from Mid Scientific, St. Louis, MO. All chemicals for 
synthesis, physical, and chemical analysis were purchased from Sigma Aldrich, St. Louis, 
MO. Gentamicin disks were obtained from Thermo Scientific, Waltham, MA. Titanium 
sheets (foils of thickness 0.1 mm) were obtained from Sigma-Aldrich, St. Louis, MO.
6.2.1 Anodization of Titanium
The anodization apparatus was set up in CTH 316. The details of the procedure 
for anodization are described in Section 3.1.7. Anodization for the titanium sheets was for 
1 ,2 ,3 , and 4 minutes. The difference in the surface of the sheet for the different time 
durations was analyzed by FE-SEM.
6.2.1.1 SBF study on the osteogenic properties o f anodized titanium. To ascertain
whether titanium retains its osteogenic potential after anodization, the sheets anodized 
for different time duration were kept immersed in simulated body fluid (SBF) for seven 
days. The SBF was replaced every day for the duration of the experiment. After seven 
days the sheets kept in SBF were gently washed and air dried for imaging under FE- 
SEM. EDX analysis was performed for elemental analysis.
6.2.2 Bacterial Inhibition Study on the GS-HNT Enhanced Hydrogel Constructs
The hydrogels enhanced with GS loaded HNTs were tested for their bactericidal
properties on Muller-Hinton agar plates. The bacterial studies were carried out for 24 
horns. If the bacteria fail to grow within the immediate 24 hours, the chances o f post- 
surgical infection due to the implant are reduced. [26,38,39,52] The details of the 
bacterial inhibition studies are given in Section 3.2.7.
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6.2.3 Release Profile Study of GS from HNTs and Hvdroeels
Enhanced with HNTs 
A release profile study was conducted for both the hydrogels and HNTs to
estimate the amount of GS released from them. The release profile procedure is explained
in details in Section 3.2.6.
6.3 Results and Discussion
This section discusses the results from the experiments from the previous section 
from the current chapter.
6.3.1 FE-SEM Imaging of the Anodized Titanium
The anodized and non-anodized titanium were imaged by FE-SEM to analyze the 
difference between their surfaces. Figure 6-2 shows the anodized titanium surfaces after 1 
minute, 2 minutes, 3 minutes, and 4 minutes and non-anodized titanium (control) for 
comparison.
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Figure 6-2. Titanium surfaces after anodization at 5|im magnification A) 1 minute B) 2 
minutes C) 3 minutes D) 4 minutes and E) Non-anodized titanium (control) at 10 jim 
magnification.
Figure 6-2 (A) shows titanium after 1 minute of anodization. The surface is not 
visibly modified and looks similar to the control in Figure 6-2 (E). The surface 
modification by anodization visibly shows after 2 minutes (B-D) and is significantly 
different in titanium anodized for 4 minutes (D). The observations from the images in 
Figure 6-2 (A-E) suggest that the titanium surface gets etched and modified after 2
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minutes of anodization. Further analysis of properties of the anodized titanium was done 
by immersing the anodized titanium in SBF for 7 days as described in the following 
section.
6.3.1.1 FE-SEM imagine and EDX o f the SBF- titanium study. The SBF-titanium
study was done to investigate if the osteogenic properties of titanium were retained 
even after anodization. This study is important to assess how anodization of titanium 
affects its osteogenic properties. If the osteogenic properties get enhanced, as suggested 
by larger and more deposits of hydroxyapatite crystals on the anodized titanium 
surface, then this would suggest that anodization would improve the biological 
properties of titanium and help in better integration of the implant in the host tissue.
Figures 6-3 and 6-4 show the results of EDX analysis for the titanium sheets kept 
immersed in SBF for 7 days. Figure 6-3 shows the EDX analysis report for control sheet 
(Non- anodized titanium).
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Figure 6-3. EDX analysis of control titanium sheet in SBF for 7 days.
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Figure 6-3 shows the graph and analysis report of the EDX analysis for the non- 
anodized titanium sheet after immersion in SBF for 7 days. Although visual inspection 
showed a thin powdery layer on the titanium sheet, the EDX could not detect any other 
element such as calcium, phosphorous, or oxygen on the surface of the sheet. The 
elemental analysis shows only titanium which is the component of the sheet. This 
analysis suggests that the deposition of hydroxyapatite on the sheet was negligible or was 
too low for the EDX to detect. Figure 6-3 shows the EDX analysis report for titanium 
anodized for 4 minutes and immersed in SBF for 7 days.
Element fft
CK 09.82 18.50
OK 40.31 56.99
NaK 00.47 00.47
PK 08.05 05.88
cm 00.00 00.00
SnL 00.00 00.00
CaK 02.28 01.28
TiK 15.63 07.38
FcK 23.44 09.49M  - C m
Matrix Correction ZAF
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Figure 6-4. EDX analysis of 4 minutes anodized titanium in SBF for 7 days.
Figure 6-4 shows the EDX elemental analysis of the 4-minute anodized titanium, 
showing the peaks for calcium, phosphorous, oxygen, and other elements. The significant 
deposition of calcium, phosphorous, and oxygen suggest that hydroxyapatite crystals 
were formed on the surface after 7 days. Only 4-minute anodized titanium sheet was used 
for the EDX analysis as the cost for running one sample was high and the observations 
from Section 6.3.1, suggested that 4 minute anodized sheets had significantly modified
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surface, compared to other anodized surfaces and the control. A visual comparison can be 
done in Figures 6-3 and 6-4 for other anodized titanium sheets and the control sheet (non- 
anodized titanium) immersed in SBF for 7 days.
Figure 6-5 shows the FE-SEM images for the surface morphology and 
hydroxyapatite crystal depositions on non-anodized titanium (control) and 4-minute 
anodized titanium.
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Figure 6-5. FE-SEM images o f A) non-anodized and B) 4 minute anodized titanium after 
7 days in SBF with the marked area showing hydroxyapatite crystal at 50 pm.
Figure 6-5 shows the smooth surface of non-anodized titanium (A) with small 
deposits of hydroxyapatite crystals shown by arrows. The surface of 4 minute anodized 
titanium shows a rough and porous surface with a big chunk o f hydroxyapatite crystal 
marked by the circle. Figure 6-6 shows FE-SEM images of the 1-minuut through 4- 
minute anodized titanium immersed in SBF for 7 days at higher magnification.
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Figure 6-6. FE-SEM images showing the different surfaces of titanium and the 
hydroxyapatite crystals after immersing in SBF for 7 days at 2 pm A) Control- Non- 
anodized titanium B) 1 minute anodized titanium C) 2 minutes anodized titanium D) 3 
minutes anodized titanium E) 4 minutes anodized titanium.
Figure 6-6 (A-E) shows the surfaces of the anodized and non-anodized titanium 
immersed in SBF after 7 days. All the anodized titanium sheets show deposition of white 
powdery spikes which are calcium phosphate or hydroxyapatite crystals (B-E). Non-
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anodized control (A) shows a thin layer of white powdery mass on its surface but it is not 
as prominent as the crystals seen on the surfaces on the anodized titanium sheets (B-E).
The 1-minute anodized sheet (B) shows larger spikes or hydroxyapatite crystals 
and the 2, 3, and 4 minute anodized sheets (C-E) show numerous small crystals on their 
surfaces. The visual comparison suggests that anodization carried for different durations 
modify the surfaces by producing different degrees of roughness and pores. This renders 
different surface properties to the titanium sheets leading to the formation of 
hydroxyapatite crystal deposits that are of different sizes and shapes. These crystals may 
be deposited in varying densities as seen in 1-minute anodized titanium sheet (B) and in 
4-minute anodized titanium sheet (E). The increased deposition of calcium phosphate 
(hydroxyapatite) on the surfaces of the anodized titanium suggests that anodization might 
improve the osteogenic and osteointegrative properties of titanium making it a better 
implant material.
6.3.2 Bacterial Inhibition Study on the GS-HNT 
Enhanced Hvdroeel Constructs
Bacterial inhibition study was done with the GS-HNT enhanced hydrogel 
constructs to investigate if the anti-infective properties of GS are retained after loading in 
die HNTs and encapsulation within the hydrogels. This study would also investigate the 
anti-infective capabilities of GS-HNT enhanced hydrogels. Figure 6-7 shows the image 
of negative control, LB agar plate with no bacterial colonies and no anti-infective agent 
GS on it after 24 hours. Sterile conditions were maintained throughout the duration of the 
study and plate was incubated at 37 °C.
Figure 6-7. Negative control plate with no bacteria and/ or anti-infective agent GS.
Figure 6-8 shows the image o f positive LB agar plate with bacterial colonies or 
lawn and without the anti-infective GS after 24 hours of inoculation.
Figure 6-8. Positive control plate with bacterial lawn and no anti-infective agent GS.
Sterile conditions were maintained for the duration of the study and the plate after 
inoculation was incubated at 37 °C. The bacterial lawn is continuous without any breaks
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or irregular empty patches. This continuity suggests that the bacteria used in the study 
were healthy and could readily form colonies on the nutrient plates after inoculation. 
Figure 6-9 (A-D) shows the images of the plates for bacterial inhibition study for anti- 
infective hydrogel constructs.
c I d
Figure 6-9. Bacterial growth inhibition studies (A) Alginate+ HNTs+ CPC+ chitosan, 
alginate* HNTs* CPC, alginate-only, and alginate* HNTs on LB agar plate. (B) 
Gentamicin control disk (60 mg gentamicin) shows a large zone of inhibition, (b) E. coli 
growing as a continuous lawn.(C) Mueller-Hinton plate with hydrogels with gentamicin 
sulfate showing zones of inhibition (top) alginate* HNTs* CPC* chitosan* gentamicin, 
(bottom) alginate* HNTs* CPC* gentamicin, (D) alginate* HNTs* gentamicin, (n=6).
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Figure 6-9 (A) shows the different compositions of the alginate hydrogels without 
anti-infective GS in the individual quadrants on a lawn of bacteria after 24 hours of 
inoculation. The hydrogels without GS do not form zones of inhibition on the bacterial 
lawn, as they do not possess anti-infective properties themselves. Figure 6-9 (B) shows 
GS standard disk (60 mg gentamicin) in first half area of the plate serving as positive 
control. The disk produces a distinct zone of inhibition on the bacterial lawn which is 
about 2 cm in diameter (measured form the center of the disk) after 24 hours of 
inoculation. The other half area of the plate shows a continuous lawn of bacteria growing 
without any irregular empty patches after 24 hours of inoculation that served as the 
negative control. Images in Figure 6-9 (C and D) show the hydrogels with gentamicin 
sulfate after 24 hours o f inoculation. The images show zones of inhibition (top) alginate* 
HNTs* CPC* chitosan* GS, (bottom) alginate* HNTs* CPC* GS in image C, and 
alginate* HNTs* GS in image D. The zones of inhibition in both the images are about 2 
cm in diameter suggesting that the GS released from the HNTs in the hydrogels inhibited 
the growth of the bacteria on the LB agar plate and have diameter comparable to the GS 
standard disk in the positive control. The results from the images of the bacterial 
inhibition study suggest that GS can inhibit the growth of the bacteria and retains its anti- 
infective properties after it is loaded into HNTs and encapsulatied into hydrogels.
To further quantify the bacterial colony-forming units (CFUs) on the control and 
experimental plates, we used an image analysis software called O penCFl/5 to count the 
CFUs. The results are summarized in Table 3.
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Table 3. Results of image analysis of the bacterial plates
Plate No. of CFUs
Negative control NA
Positive control 765
Outside zone of inhibition Near the beads
Alginate+ HNTs+ GS 422 16
Alginate+ CPC+/-Chitosan+ 
HNTs+GS
998 11
The numbers of CFUs near the beads containing GS loaded HNTs were small
compared to the number of CFUs growing on the agar plate away from the zone of
inhibition as can be seen in the summarized results in Table 3. The number was not zero
as the regions of interest selected also included the peripheries of the zone of inhibition
where the boundaries are not sharply defined.
6.3.3 Release Profile Study of GS from HNTs and Hvdroeels 
Enhanced with HNTs
The release profile study of GS-loaded HNTs and of hydrogel composites 
enhanced with GS-loaded HNTs was performed to estimate the amount of GS released 
from HNTs and hydrogels.
The release study for GS from HNTs was done for a period of 7 days. Figure 6-10 
shows calibration curve for GS used to calculate the concentrations for GS released from 
HNTs for 7 days.
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Figure 6-10. Calibration curve for GS used to calculate GS concentrations released from 
HNTs for 7 days (n=6).
Figure 6-10 shows a calibration graph of absorbance versus concentration (mg/ 
ml). This graph gives the corresponding values for GS released from HNTs at a particular 
absorbance. Figure 6-11 shows the cumulative release of GS from HNTs for 7 days.
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Figure 6-11. The cumulative release of GS from HNTs for 7 days.
Figure 6-11 shows the cumulative release of GS from HNTs for 7 days. The 
release for GS from HNTs was extended and sustained for a period of 72 hours and the 
points after 72 hours reach a plateau, as can be seen from the graph. The release study 
was repeated three times and each time the samples were collected in duplicates (n=6). 
The release profile of GS from the HNTs for a period of 7 days shows a release 
characterized by an initial high burst of release within the initial 24 hours and a later little 
additional release. The initial high burst of release within the initial 24 hours can be 
attributed to the drug being coated on the outer surface as well as the drug loaded in the 
lumen coming out as a high burst. The release of GS differs from that o f the BMP 2 
molecule discussed in the previous chapters because of the size difference of the 
molecules. BMP 2 is a protein and its molecular size is larger than Gentamicin sulfate
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which is an aminoglycoside. As most of the drug comes off from the lumen within the 
period of initial 24 hours there is little drug coming out in the later stage of the study.
The cumulative release profiles of GS from HNTs in hydrogel composites were obtained 
for a period of 7 days. Figure 6-12 shows the cumulative release profiles of GS from 
HNTs in hydrogel composites for 7 days. The error bars represent the standard deviation 
calculated by the standard deviation of the data point and the average of the triplicate 
samples (detailed process of calculation of the standard deviation described in Appendix 
B). [59]
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Figure 6-12. Cumulative graph of gentamicin sulfate release from hydrogels showing 
time (hours) vs. concentration (mg/ ml).
Figure 6-12 shows a cumulative release profile for GS from HNTs in hydrogel 
composites for 7 days. The graph shows time (hours) versus concentration (mg/1) of the 
GS released from the HNT enhanced hydrogel composite- alginate+CPC+HNTs+ GS
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(green squares) and compared against alginate+CPC+ 2% v/v GS (blue triangles) and 
HNTs only (red rhombus). The calibration curve shown in Figure 6-10 was used to 
calculate the concentrations of GS released. The error bars represent the standard 
deviation calculated by the standard deviation of the data point and the average o f the 
triplicate samples (detailed process of calculation of the standard deviation described in 
Appendix B). [59]
The comparative study of the cumulative release of GS from different constructs 
shows that all the release profiles are defined by a characteristic initial high burst of drug 
release in the initial 24 hours and a later small additional release. The initial high burst of 
release within the initial 24 hours can be attributed to the drug being coated on the outer 
surface as well as the drug loaded in the lumen coming out as a high burst. As most o f the 
drug comes off from the lumen within the period of initial 24 hours there is little drug 
coming out in the later stage of the study.
A comparison o f the initial high burst values of different constructs (CPC 2% GS 
v/s HNTs and CPC-HNT GS) reveals that loading GS in HNTs might reduce the amount 
o f GS being released in the initial 24 hours, extending the release to 48 hours. This 
delayed release might be caused by the drug molecules being trapped in the inner lumen 
and the concentric layers of aluminosilicate and released in a slightly delayed manner.
For implants to be successful, formation of bacterial films on the surface of the 
implants has to be prevented. Usually, infection sets in within the first 24 hours. [38, 39, 
40] For the prevention of infection, first 24 hours after implantation are crucial and an 
anti-infective needs to be supplied in a sustained manner over an extended period beyond 
24 hours. The observations from Figures 6-7,6-8,6-9,6-11, and 6-12 suggest that the
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hydrogel composites enhanced with GS loaded HNTs would be a better anti-infective 
delivery system as the anti-infective GS would be released for an extended period of 48 
hours which would prevent the bacterial growth on the implants.
CHAPTER 7 
CONCLUSIONS AND FUTURE WORK
Chapters 4 ,5 , and 6, discussed three projects with interrelated concepts and novel 
application of hydrogels, nanoparticles and anodized titanium. The cuirent chapter 
synthesizes the recorded observations and integrates them with concepts from Chapters 4, 
5, and 6. A plan for the future direction of this work is also provided.
Chapter 4 discussed in detail the testing of the hypothesis that the addition of 
HNTs and growth factors to alginate hydrogels will improve the hydrogels’ biological 
performance and material properties. The observations from the results suggest that the 
cells performed better in the alginate hydrogels with growth factor-loaded halloysites. 
Among the three growth factors used (BMP 2,4, and 6), histochemical staining and 
analysis revealed that alginate hydrogels with BMP 6 and BMP 2+ 0.4M ascorbate 
medium performed better than the rest of the groups. BMP 2 is FDA approved for use in 
orthopedic and orthodontic applications. [13] Hence, it can be used in combination with
0.4 M ascorbate medium to yield best results with osteogenic response. The release of 
BMP 2 from halloysite was sustained and extended suggesting that the growth factor can 
be made available to the regenerating tissue throughout a seven day period, and at low 
amounts, which is crucial for cellular differentiation and maturation.
The release of BMP 4 and 6 could not be studied, as the customized kits for 
ELISA are not available commercially. In future studies, the release profiles of BMP 4
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and 6 can be studied and compared to the release profile of BMP 2. These studies will 
reveal the pattern of release of these growth factors from halloysite and hydrogels. The 
behavior of die cells and the formation of hydroxyapatite crystals after mineralization can 
be studied by performing micro-CT (computational tomography) analysis on the 
hydrogels with osteoblasts encapsulated in them. This analysis would provide 
visualization of the three dimensional constructs, orientation o f the cells and mineral 
deposits after cellular differentiation.
Chapter 5 discussed in detail the concept of “nanoseeds” or Nanoenhanced 
alginate hydrogel composites as potential chemoattractant materials. The primary 
hypothesis was to test if  these constructs could attract the Osteoprogenitor cells towards 
them through molecular signaling by release of BMP 2. The histochemical analyses 
showed that the cells in the wells with growth factor-loaded HNT enhanced alginate 
hydrogel composites migrated towards the source of molecular signal, the hydrogel bead. 
It can be concluded from the observations that the “nanoseeds” can act as 
chemoattractants and can be used to accelerate the process of bone regeneration when 
used in combination with metal implant materials. The material testing also revealed that 
the material properties are altered by the addition of the composite materials (HNTs, 
CPC, and chitosan lactate).
NucBlue fluorescent staining results were not included as the stain faded after 
Day 3 of die migration study. The images for the NucBlue staining method were 
inconclusive but the same wells when stained with histochemical stains such as Alcian 
Blue and Von Kossa, showed that the cells had migrated from their site of seeding 
towards the molecular signal (the hydrogel composite beads with BMP 2). In future
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studies, the modified behavior of the migrating cells can be studied at the molecular and 
genetic level by performing PCR and western blots to visualize the levels of osteogenic 
markers and gene segments expressed. To understand the material properties of the 
composite hydrogels and the interaction between the materials, Nanoindentation studies 
can be performed on the hydrogel constructs. Nanoindentation studies would quantify the 
surface roughness and other material features of the hydrogel constructs. The pilot study 
with the preosteoblasts being seeded directly on the composite hydrogel films can be 
extended into a full study.
Chapter 6 described the surface modification of the titanium by anodization and 
enhancing the alginate hydrogel composites with HNTs and GS (anti-infective agent).
The primary hypothesis of the project was to improve the osteogenic properties of 
titanium making it more osteointegrative and prevent the growth of bacteria on its 
surface. The observations from the results showed that the osteogenic properties were 
improved upon anodization with 4 minutes of anodization producing the most modified 
surface and having the highest deposition of calcium phosphate (hydroxyapatite crystals). 
The bacterial inhibition studies showed that the alginate hydrogel composites with GS 
could prevent the growth o f bacteria. It can be concluded from the observations that 
anodization of titanium and coating the surface of the metal with anti-infective hydrogels 
would prevent the bacterial growth and improve its osteogenic properties.
Mammalian cellular studies with co-culture of bacteria can be performed in the 
future, to assess the performance of anodized titanium coated with anti-infective hydrogel 
coatings in simulated internal environment. In the future, the in vitro studies can be 
extended to in vivo studies with animal models. Anodized titanium can be tested for
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cellular response by seeding osteoblasts directly on the metal surface for an extended 
period of 28 days or more. Bacterial inhibition studies can also be extended beyond 24 
hours if the bacteria can be cultured for an extended period. The bacterial studies can be 
done with other bacterial species like Staphylococcus.
All the above projects were tested in vitro due to time and resource constraints. 
Future studies can extend these projects to in vivo testing on animal models. The scope of 
all the projects in this dissertation was limited to the osteogenic aspect of bone 
regeneration. The skeletal regeneration has other aspects like angiogenesis and bone 
remodeling. These aspects can be studied in the future by selecting angiogenic growth 
factors and conducting the studies on co-cultures containing skeletal cell lines (e.g. 
myoblasts, osteoblasts, mesenchymal stem cells, and chondrocytes).
An investigative study on the effect of growth factors, nanoparticles and hydrogel 
composites on cell behavior with a comparison between murine bone cell lines and 
human bone cell lines can help to predict the behavior of these constructs in humans as 
implant materials. As with any research, the experimental design can be improved. The 
experiments can be extended to 28 days, more advanced imaging techniques, like micro- 
CT, or mechanical testing, like Nanoindentation, can be used to quantify the results that 
are discussed in this dissertation. The three projects indicate that the constructs hold 
promise as potential implant materials that can overcome some limitations of the current 
commercially available implant materials.
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IMAGE ANALYSIS
For quantifying the values of the intensities of RGB colors in the histochemically 
stained hydrogel sections we used Image J® software. The software plotted graphs for 
RGB peaks and grayscale intensity values. This image analysis was used to substantiate 
the observations and inferences drawn in the histological staining images in Sections 
4.3.1.1,4.3.1.2, and 4.3.1.3.
The method used in this dissertation for Image J image analysis can be 
summarized as follows:
Open Image J • Click on 'File'
In the drop down 
menu click on 
'Open' and select 
the image to be 
analyzed
Click on 
'Analyze' 
and select a 
region of 
interest
A graph of RGB 
peaks and color 
intensity will be 
displayed.
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RELEASE STUDY PLOT AND ERROR BARS
The process of release study and plotting the graphs can be summarized as
Sample
collection
Recording 
readings & 
plotting graphs
At least 3 samples were collected for a particular time 
point and stored in air-tight capped tubes at 4 °C
Assay to calculate 
the optical density 
(OD)
•The choice o f assay to perform to read the OD o f the sample 
depends on the nature o f the sample.
•In case o f BMP 2 we used ELISA custom-made kits known for 
their high sensitivity (pg/ ml and ng/ml)
•In case o f Gentamicin we sued OPTA reagent assay and 
UV/VIS spectrophotometry
•The readings were recorded as individual time points in MS Excel 
worksheet as raw data. These data points were then averaged and 
their averages were used to obtain the cumulative values for the 
release.
•The cumulative values were the sum of the current data point 
average and the previous data point average. E.g. If A, B, and C 
are the averages of the two data points then the cumulative release 
points will be 1) A, 2) A+B, 3)A+B+C,...
•The cumulative values for release were then used to plot the 
cumulative release graph.
• Standard error was used to estimate the error as it calculates the 
accuracy of the values with thier means.
follows:
In the article by Zheng et al., 2011 in the Journal of Dmg Delivery, the 
authors describe four types of release profiles and describe the curve as either having
initial high/ low burst release or late little/ extended release. In this dissertation, we used
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this model to describe the release profiles of the growth factor BMP 2 and 
antibiotic Gentamicin.
We chose to use standard deviation bars to represent the deviation from the 
average of each point. The author uses averages and standard deviation for each point to 
plot the error bars for the cumulative plot. The standard deviation is calculated as
where S.D. is the standard deviation of that point, .vis the data point, x  is the average of 
the readings and N is the number of samples taken for that point.
For calculating the concentrations we plotted a calibration curve for the respective 
bioactive molecule by using known standards and their corresponding absorbance values. 
The absorbance values shown by the experimental samples were then plotted using the 
equations mentioned in the calibration curves to find the concentrations. The final graph 
was the plot of the concentrations calculated from the calibration curves and the 
corresponding time points. For the BMP 2 plot, the graph is not a cumulative plot but the 
plot of individual data points and shows a general representation of the concentrations for 
the particular time point.
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EXPERIMENTS WITH 
INCONCLUSIVE RESULTS 
AND FAILURES
The following is the list and a brief description of the experiments that were 
conducted on the hydrogel constructs to investigate either their biological or material 
properties which had inconclusive results or failed to perform in the given conditions.
1. NucBlue fluorescent staining assay.
^ ♦ »The NucBlue ' fluorescent staining assay was performed to visualize the cells in 
collagen gel matrix for the Nanoseeds project. The cells were first stained with the 
protocol provided by the manufacturers and then seeded on the collagen gel matrices. 
The study was to be carried out for 7 days and with samples imaged on days 0, 3, and 
7. The NucBlue stain is a vital stain and helps in visualization of the cells without 
requiring sample processing and fixing. The stain faded out after Day 3 and the 
results were inconclusive as the migration of the cells towards the chemoattractant 
hydrogel beads could not be visualized.
We had to rely on the histochemical staining (Alcian Blue and Von Kossa stains) 
which had better visualization of the cells along with ECM materials and minerals to 
study the cellular migration.
2. Nanoindentation of the hydrogel constructs.
The hydrogel composite samples were sent to University of Wisconsin, Milwaukee to 
quantify and analyze their material properties like surface roughness, elasticity, and
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pore distribution by Nanoindentation technique. It was courtesy of Dr. Lobat Tayebi 
who referred Dr. Steve Hardcastle as the point of contact and testing of the samples. 
Dr. Hardcastle encountered difficulties in performing the Nanoindentation technique 
on the hydrogels as the samples kept rupturing and the tip was not suitable to be used 
on our samples. We were advised to obtain diamond tips and the study had to be kept 
on hold due to the high cost of the tips and the tests.
1. Gradient Tech* cell migration study.
To study the cell migration of the preosteoblast towards the loaded and unloaded 
HNTs, we tried using Gradient Tech cell migration 2D construct. The study was 
inconclusive as it required the use of fluorescent microscope for 48 hours. The results 
obtained for a period of 8 hours were inconclusive and we had to settle for the 
histological staining of the cells seeded on the collagen gel matrices.
